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Objectives: The aims of the thesis were to assess coronary artery
remodelling and plaque load, and to determine whether this influences
vascular and endothelial function in vivo in man.
Methods: Coronary artery remodelled segments were categorised using
intravascular ultrasound (IVUS). Plaque type was characterised directly
from spectral analysis of the radiofrequency ultrasound signal. Central
arterial stiffness was assessed using non-invasive measures of arterial
stiffness obtained by applanation tonometry of the radial, carotid and
femoral artery. Coronary artery plaque volume was determined following
computerised three-dimensional reconstruction of IVUS images obtained
during a motorised pullback device. Coronary vessel area, arterial stiffness
and vasomotor responses were determined using IVUS and Doppler Flow
measurement and endothelial fibrinolytic responses by coronary sinus
sampling during selective intracoronary infusions.
Results: Plaque characteristics Positively remodelled segments had a
larger vessel area (16.5±1.1 mm2 vs. 8.7±0.9 mm2, p<0.01) and plaque area
(7.3+1.1 mm2 vs. 4.4+0.8 mm2, p=0.05) than negatively remodelled
segments. Both positive and negatively remodelled segments had a greater
percentage of fibrous plaque (p<0.01) than calcified or lipid rich plaque.
Comparing positively and negatively remodelled segments, there was no
significant difference between the proportion of fibrous, calcified and lipid
rich plaque. Comparisons with non-invasive measures Plaque volume
positively correlated with carotid-radial pulse wave velocity (r=0.47,
p=0.008) and appeared to correlate with carotid-femoral pulse wave
velocity (r=0.34, p=0.07). Aortic augmentation (r=0.24, p=0.16),
augmentation index (r=0.3, p=0.08), and pulse pressure (r=0.22, p=0.2) did
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not significantly correlate with proximal coronary artery plaque volume.
Structure and function In comparison to non- and positively remodelled
segments, negatively remodelled segments had a higher stiffness index
(67±16 vs. 33±5 and 38±8 respectively; p<0.02). A significant degree of
preservation of vasodilatation to 10"6 M acetylcholine was evident in
positively remodelled compared with negatively remodelled segments
(p<0.05). Coronary blood flow increased with both substance P and
sodium nitroprusside infusions (p<0.001), although coronary sinus plasma
t-PA antigen and activity concentrations increased only during substance P
infusion (p<0.006 for both). There was a significant inverse correlation
between coronary artery plaque burden and the release of active t-PA (r=-
0.61, p=0.003).
Conclusions: Pulse wave analysis may be a useful non-invasive surrogate
marker for the extent of coronary atherosclerosis. Atherosclerotic risk
factors and coronary plaque load are associated with impaired vasomotor
and endogenous fibrinolytic function. Though plaque type was similar in
remodelled types, negative remodelling was associated with more
pronounced local vascular and endothelial dysfunction. These findings
collectively suggest an important local interrelationship between coronary
vascular structure and function that has implications for the
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1.1 Coronary Artery Remodelling
1.1.1 His torical Perspective
The ability of an artery to expand to accommodate plaque was first noted,
in 1972, from an autopsy series of Masai tribesman where significantly
enlarged coronary arteries on external inspection were noted to contain a
substantial atherosclerotic plaque burden (Mann et al 1972). This plaque
load, with a concomitant increase in lumen area, was greater than seen in
matched North American subjects.
Further observational studies by Glagov and colleagues (Glagov et al
1987; Zarins et al 1988), confirmed the ability of coronary arteries to
expand to accommodate increasing atherosclerotic plaque (Clarkson et al
1994; McPherson et al 1991). From analysis of human left main stem
histological segments, it was concluded that coronary arteries enlarge with
the increase in the lesion area and only when plaque constituted 40% of the
total vessel area did luminal compromise occur. This process was termed
compensatory enlargement (Glagov et al, 1987)(Figure 1.1).
Subsequent intravascular ultrasound (IVUS) and post mortem studies have
shown that the extent of remodelling in a given artery may be highly
variable with segments of positive remodelling (vessel expansion), no
change, and negative remodelling (vessel shrinkage) with encroachment on
lumen area (Pasterkamp et al 1995; Nishioka et al 1996).
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Figure 1.1 Glagov's Coronary Artery Remodelling Hypothesis
Progression
Compensatory expansion Expansion overcome:
maintains constant lumen lumen narrows
Normal Minimal Moderate Severe
vessel CAD CAD CAD
Adapted from Glagov et al, NEngl JMed 1987;316:1371-1375
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1.1.2 Pa thophysiology
The term remodelling is now used in de novo atherosclerosis, restenosis
and transplant vasculopathy, though the underlying mechanisms may be
different.
Remodelling and de novo atherosclerosis
Remodelling is a dynamic process with an artery responding to changes in
shear stress and wall tension (Langille et al 1996; Ward et al 2000).
Previous work has suggested that with increasing plaque load, vascular
response to shear stress is preserved (Krams et al 1998; Dirksen et al 1998;
Smedby et al 1997). Increased shear stress may potentiate positive
remodelling through endothelial production of nitric oxide (Tronc et al
1996) with an increase in matrix metalloproteinase activity (Lee et al 1996;
Sasaki et al 1998) and apoptosis of smooth muscle cells (Cooke et al
1997). Furthermore, shear stress leads to enhanced expression of adhesion
molecules (ICAM-1 and VCAM) (Walpola et al 1995) with increased
inflammatory cell infiltration into the plaque, and a local increase in
macrophages and T-cell activity (Dirksen et al 1998). In contrast, with low
flow states, production of growth factors predominate (TGF-B, PDGF),
with a resultant increase in smooth muscle cells and collagen deposition
which potentially mediates negative remodelling (Mondy et al 1997;
Bassiouny et al 1998).
Remodelling and restenosis
After coronary intervention, there appears to be an acceleration of the
remodelling process, as described by intravascular ultrasound. Di Mario et
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al described immediate and late changes in 34 patients after balloon
angioplasty (PTCA) and directional coronary atherectomy (DCA) (Di
Mario et al 1995). A reduction in plaque area was the main operative
mechanism of DCA accounting for 66% of acute lumen enlargement,
compared to balloon angioplasty where this accounted for 52% of the
increase in lumen area. There was also a significant increase in total vessel
area in both groups thus accounting for 48% and 34% of the acute lumen
gain in PTCA and DCA groups, respectively. After 6 months, in the DCA
group, an increase in plaque area was the predominant mechanism of late
lumen loss (92%) whereas this accounted for only 33% of loss after PTCA,
the remainder coming from a reduction in total vessel area (late recoil or
negative remodelling).
In another study, 209 patients underwent serial ultrasound and
angiography pre- and post-intervention at mean 6 months follow-up (Mintz
et al 1996). A total of 73% of the reduction in lumen area from post-
intervention to follow-up was due to a decrease in vessel size with the
remainder due to an increase in plaque area. As expected, this negative
remodelling process was most pronounced in those patients with
angiographic restenosis (defined as a diameter stenosis >50% by
angiography). During follow-up, 22% of lesions showed an increase in
total vessel area complementing an increase in plaque area (positive
remodelling). These lesions had no overall change in the lumen area
although 49% of them demonstrated a late lumen gain with a restenosis
rate of 26% compared to that of 62% in lesions showing a decrease in total
vessel area.
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The relationship between acute lumen gain and late lumen loss was
analysed in a prospective serial ultrasound and angiographic study after
balloon angioplasty or DCA (Kimura et al 1996a). Late lumen loss
correlated closely with the reduction in vessel area and increase in plaque
area, although only the increase in vessel area was related to the acute gain
suggesting that arterial remodelling but not changes in plaque volume was
indicative of a generalised response to injury (Kimura et al 1996b). This
was subsequently confirmed in a porcine model of deep wall injury, where
although the degree of injury correlated with neointimal formation, the
final lumen size was more closely related to the final vessel size
confirming that arterial remodelling was more important than neointimal
hyperplasia, in determining late luminal narrowing (Anderson et al 1996).
The response of the adventitia to vascular injury is an attractive hypothesis
towards the development of negative remodelling. An early correlation
was noted between the degree of adventitial inflammation and the severity
of disease in the overlying arterial wall (Schwartz et al 1962). Given the
barotrauma of coronary intervention, the adventitia proliferates within two
days from the stretch/pressure stimulus gradually abating between one and
two weeks from the event, even supplying proliferating cells to the
neointima (Scott et al 1996). Work defining the three-dimensional network
of the (adventitial) vaso vasorum using microscopic computer tomography
confirms neovascularisation after balloon injury with an increase in
circumferential blood vessel density and an association with lesion severity
(Kwon et al 1998). It has been hypothesised that the degree of barotrauma
and endothelial disruption at the time of intervention accelerates the
negative remodelling process through an inability of adventitia to
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accommodate the residual plaque load. The reduced restenosis rates with
the antioxidant probucol, attributed to preserved positive remodelling in
the presence of an increased plaque load, may thus be due to a relative
preservation of endothelial function. However, it is not known, whether
endothelial function in a segment of a diseased vessel modulates the ability
of adventitia to expand to accommodate an increasing plaque load in the
absence of intervention.
Remodelling in transplant vasculopathies
Both positive and negative remodelling has been described in transplanted
hearts. Though haemodynamic stimuli exist as in the native coronary
circulation, the effect of denervation on remodelling is unknown. Previous
improvements in stenosis severity by angiography with HMG-CoA
reductase inhibitors has been attributed following IVUS studies to a
reduction in intimal growth as opposed to positive remodelling. An in-vivo
IVUS study investigated 27 patients with minimal or no epicardial
transplant coronary artery disease during their annual angiographic follow
up (Schwarzacher et al 2000). The degree of coronary remodeling (as
estimated by the ratio of total vessel area / [total vessel area - lumen area])
was significantly greater in eccentric lesions compared to concentric
lesions, despite similar intimal-medial areas, suggesting that plaque
topography may influence the remodelling response. Eccentric lesions also
had significantly greater compliance suggestive of preserved endothelial
function (or a section of dynamic vasomotor function in the less diseased
arc) though whether this determines the remodelling response is unknown.
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Remodelling and Clinical Observations
The absence of longitudinal studies has led to speculation as to whether
positive and negative remodelling is part of the same pathological process.
With different types of remodelling in the same vessel it suggests that
lesion specific factors for example plaque type, degree of inflammation,
shear stress, age of a lesion and vessel angulation may be more important
than patient specific factors.
The mechanisms determining why the vessel can only accommodate a
certain amount of plaque before positive remodelling is exhausted is
unknown. Previous work using quantitative coronary angiography in
patients with normal angiograms or mild coronary artery disease has
suggested that positive remodelling may occur early in the development of
atherosclerosis (Lerman et al 1998). Loose connective tissue and lipid
accumulation have been associated with early development of
atherosclerosis (Di Mario et al 1992), with fibrotic and calcified lesions
evident at a later stage (Stary et al 1995). Calcification has been associated
with negative remodelling (Mintz et al 1997; Sabate et al 1999), as well as
unrelated to the form of remodelling (Weissman et al 1999). However, the
hypothesis that negative segments represent a late stage of atherosclerosis,
where the plaque segment underwent positive remodelling first, is difficult
to justify in the absence of longitudinal studies. Longitudinal studies,
however, in view of the slow development of stable atherosclerotic plaque
makes this impractical, expensive, and ethically difficult. However with
on-going development of noninvasive methods of coronary imaging such




Coronary lesions with positive remodelling, as opposed to lesions with
negative remodelling have a greater plaque volume by 3D reconstruction
of IVUS images (Von Birgelen et al 1998). Plaque rupture in an acute
coronary syndrome occurs at sites where vessels show a greater degree of
positive remodelling than in stable lesions (Schwarzacher et al 1998;
Jeremias et al 2000; Shoenhagen et al 2000). Indeed patients presenting
with stable angina were more likely to present with culprit lesions which
are negatively remodelled (Shoenhagen et al 2000) often with more fibrous
and calcified plaques (Kearney et al 1996). In a detailed histological
study, immunohistochemical staining of post mortem atherosclerotic
arteries demonstrated more markers of plaque vulnerability (increased
macrophages and lymphocytes, less collagen and smooth muscle cells) in
sections with a larger plaque to vessel area, i.e. positively remodelled
vessels (Pasterkamp et al 1998). Ironically, this suggests that although
positive remodelling allows the vessel to expand to avoid lumen
encroachment and the potential for coronary flow-limitation, it may lead to
instability in the plaque increasing its likelihood for erosion and rupture.
Following lipid-lowering treatment in atherogenic rabbits, there is
evidence for plaque stabilisation with reduced accumulation of
macrophages and expression of metalloproteinases, along with greater
collagen accumulation (Aikawa et al 1998; Pasterkamp et al 1998).
Whether the increased risk for instability in positively remodelled arteries
is modulated by changes in the integrity or function of the overlying
endothelium is unknown.
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1.2 Limitations of Coronary Angiography
Since the late 1950s, the gold standard for the anatomical assessment of
coronary arteries was selective coronary angiography (Judkins et al 1967;
Sones et al 1972). However, although becoming widely applicable for the
assessment and management of coronary artery disease, limited
information is available from angiography about plaque load. Images are
taken at different angles, with the image illustrating the minimum lumen
diameter taken as the index picture of the greatest lesion severity, which
may not be the case. Angiography describes a two-dimensional silhouette
of a contrast-filled lumen, however, there are many limitations both with
respect to image quality and the inability to examine the arterial wall
directly. Angiography depends on adjacent segments tc characterise lesion
severity but the normal reference segment is frequently diseased due to the
diffuse nature of atherosclerosis (Mintz et al 1995), leading to an
underestimation of disease severity. Accurate quantitative angiography
requires computer-assisted edge detection and in specific situations such as
in eccentric or ostial lesions, and with vessel fore-shortening and overlap,
there is a difficulty in interpretation with wide interobserver variability.
Problems with accurate angiographic quantitation are frequently
accentuated after coronary intervention due to plaque rupture and
dissection with the subsequent appearance of a hazy lumen of
indeterminate severity. The absolute resolution of image intensifies is also
limited by radiation dose considerations and by rapid coronary artery
motion, leading to an image blur of up to 0.5 mm (Topol et al 1995).
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In addition to issue with image resolution and appearance, the inability of
angiography to detect this occult disease may also be due to the presence
of positive remodelling and the diffuse nature of disease throughout the
entire vessel length in many patients. Furthermore, important pathological
features not demonstrated by angiography include plaque composition, in
particular the presence of a lipid-rich or fibrous plaque, and thus an
indication of the stability/vulnerability of the plaque. As a result, the
degree of stenosis has been shown to be a weak indicator as to whether
plaque will eventually cause a myocardial infarction (Falk et al, 1995).
As a consequence of these differences between the two imaging
modalities, significant discrepancies have been found between IVUS and
angiography: lesions were classified more frequently as eccentric by
ultrasound than by angiography, 77% vs. 33%. Target lesion calcification
was documented in 62% of cases by ultrasound but only 35% of
angiograms and after angioplasty, fracture or dissection of plaque was
described in 49% of lesions by ultrasound compared to 22% of angiograms
(Fitzgerald et al, 1993).
Angiography by virtue of being a lumenogram is still unable to allow
complete assessment of coronary plaque and yet is widely used in many
coronary atherosclerosis trials. In several small plaque regression trials
(FATS, STARS), little difference was seen in coronary stenosis severity
using quantitative angiography at follow-up despite large differences in
clinical outcome (Brown et al 1993). This suggests that the ability to study
relatively mild (<50% diameter stenosis by angiography) but potentially
unstable stenoses by intravascular ultrasound may give additional
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information regarding clinical outcome and emphases the need for
complementary methods of imaging coronary arteries.
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1.3 Intravascular Ultrasound (IVUS)
1.3.1 Introduction
The technology to image coronary plaque in vivo only became available in
the late 1980s with the development of catheter based intravascular
ultrasound which has revolutionized our understanding of atherosclerotic
coronary artery disease (Yock et al 1989). As previously discussed
angiography is limited in its ability to assess the disease process
accurately, and to define plaque composition and extent. Advances in
miniturisation has led to ultrasound catheters as small as 2.6F (c. 0.9 mm)
diameter, without loss of image quality. IVUS gives two-dimensional
information regarding the arterial layers in cross-section, providing, both a
visual and quantitative assessment of plaque burden with the potential to
reconstruct this information three-dimensionally off-line (Figure 1.2).
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Figure 1.2 Coronary arterial remodelling associated with





















IVUS provides information about plaque composition (Nishimura et al
1990; Tobis et al 1991). Classification of plaque by the IVUS subgroup of
the Working Group of Echocardiography of the European Society of
Cardiology defined plaque characteristics as homogenous or mixed.
Homogenous related to soft (echolucent or low echoreflectivity), fibrous
(similar echoreflectivity to adventitia), or calcific plaque (high
echoreflectivity with shadowing respectively). Mixed plaque constituted
the following combinations: soft/fibrous, soft/calcific and fibrocalcific (Di
Mario et al, 1998) (Table 1.1).
IVUS permits accurate quantification of coronary atherosclerotic plaque.
Only a small degree of inter-observer variability has been confirmed in
several studies as lateral dropout and distortion of the image can cause a
small difference between the interpretation of different observers (R=0.93-
0.98). Catheter movement during the cardiac cycle has not been
substantiated as a significant cause of error (Kearney et al, 1995a).
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soft soft / fibrous
fibrous soft / calcific
calcific1 fibrocalcific
*
>80% area constituted by the same plaque components. No calcium or
focal calcium deposits (arc of calcium <10 degrees)
+
presence of multiple plaque components not matching the 80% criterion
ofprevalence
1 total calcific arc >180 degrees
Modified from Di Mario et al, Eur Heart J\ 19:207-229.
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Radiofrequency analysis
Previous methods in characterising atheromatous plaque include both
visual analysis and comparison of intima with the echo-reflectivity of the
adventitia (Gussenhoven et al 1989; Siegel et al 1992; Di Mario et al 1992)
and videodensitometric analysis (Peters et al 1994; Rasheed et al 1995) of
a grey scale level. These methods, however, are difficult to reproduce in
view of the poor resolution provided by the video image along with
various post-processing operations that are applied to the ultrasound signal
such as the gain settings of the image (Kearney et al 1995b).
The unprocessed radio-frequency (RF) signal from ultrasound scanners
provides a more reproducible source of data. Plaque characterisation using
the power spectral analysis from raw ultrasound information has been
described in both coronary (Dixon et al 1997; Spencer et al 1997; Moore et
al 1998; Watson et al 2000; Nair et al 2002) and carotid arteries (Noritomi
et al 1997a, 1997b).
In an animal model of allograft rejection, RF analysis of unprocessed
intravascular ultrasound signal "backscatter" was found to be more
sensitive in characterising tissue than visual or quantitative grey-scale
analysis (Jeremias et al 1999). Watson et al selected 299 regions-of-
interest (ROI) from eight post-mortem coronary arteries using a 30MHz
IVTJS scanner. Predominant plaque composition of the vessel wall was
identified by routine histology and staining. A suture needle inserted in the
vessel wall throughout the IVUS pullback showed clearly on the IVUS
image and allowed alignment of the IVUS data with histology. With RF
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analysis defined in terms of spectral features, 86% of coronary plaque was
correctly classified into one of three categories (mixed fibrous tissue, lipid-
rich plaque and calcified plaque) (Watson et al 2000).
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1.4 Endothelial Function in Coronary Artery Disease
The endothelium plays a central role in the maintenance of normal
vascular function and homeostasis including the control of blood flow,
coagulation, fibrinolysis and inflammation. Consequently, the maintenance
and regulation of tissue perfusion critically depends upon the integrity of
endothelial function and the release of various endothelium-derived
factors.
1.4.1 Endothelial Dysfunction
The endothelium-dependent regulation of peripheral vascular tone is
impaired by many of the risk factors associated with atherosclerosis, such
as hypercholesterolaemia (Chowienczyk et al 1992; Stroes et al 1995;
Heitzer et al 1996a), diabetes mellitus (Calver et aI 1992), a familial
history of atherosclerosis (Celermajer et al 1992), hypertension (Vanhoutte
1996) and smoking (Celermajer et al 1996; Heitzer et al 1996a+b; Newby
et al 1999a]. This dysfunction appears to be generalised with demonstrable
impairment of endothelial function in the coronary circulation of patients
with coronary artery disease (Ludmer et al 1986) and its risk factors (Vita
et al 1990) including smoking (Zeiher et al 1995). Moreover, the greatest
constrictor response to the endothelium-dependent vasodilator,
acetylcholine, was described in those with most risk factors (Vita et al
1990)
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1.4.2 Plaque Load and Endothelial Dysfunction
Endothelial dysfunction may be the earliest manifestation of the
atherosclerotic disease process and account for many of the abnormalities
documented in regional tissue perfusion that occur before the development
of obstructive coronary artery disease (Uren and Crake 1996).
With the development of atheroma, endothelial-dependent relaxation to a
variety of different vasoactive agents is impaired. Acetylcholine infusion
may even cause paradoxical vasoconstriction in patients with coronary
artery disease (Ludmer et al 1986). Coronary artery disease is a diffuse
process with more than one discreet lesion affecting some or all of the
main epicardial coronary arteries along with a variable degree of
endothelial dysfunction. Concomitantly, the atherosclerotic process
appears to have a similar effect on coronary vasomotor tone in epicardial
vessels and resistive vessel function in man (Uren and Crake 1996).
Normal epicardial vessels dilate in response to increasing flow induced by
the effect of a vasodilator such as intracoronary papaverine on the resistive
vessels (Drexler et al 1989). However, flow-dependent coronary
vasodilatation is reduced in atherosclerotic arteries. Zeiher et al studied
the coronary vasomotor responses to three different endothelium-mediated
stimuli; acetylcholine, increasing blood flow, and sympathetic activation
by cold pressor testing in different patients (Zeiher et al 1991). All three
stimuli dilated angiographically normal coronary arteries in subjects with
no cardiovascular risk factors. Subjects with normal arteries but
hypercholesterolaemia sustained vasoconstriction to acetylcholine.
33
Patients with a normal artery by angiography but with disease elsewhere
showed both vasoconstriction to both acetylcholine and cold pressor, with
preservation of flow-dependent vasodilatation. Patients with angiographic
wall irregularities showed abolition of vasodilatation to all three stimuli,
thus indicating a hierarchy of impairment on endothelial-dependent
vasodilatation in epicardial arteries with progression of the atherosclerotic
process. In the microcirculation, the dilator response to acetylcholine was
markedly reduced in patients with angiographically normal epicardial
arteries and hypercholesterolaemia, compared to the other groups.
Patients with angiographically normal arteries but disease elsewhere also
showed a reduced vasodilator response to acetylcholine, but this was
found in those with a raised LDL-cholesterol. However, the epicaridial
vasodilator response to papaverine (flow-dependent vasodilatation) was
lower only in those with angiographic disease of the study artery compared
to the control group. Thus, there is progressive impairment in
endothelium-dependent vasodilatation in patients at different stages of
early atherosclerosis. In the IVUS era, it is interesting to speculate that the
hierarchy of response in vessels defined by their angiographic appearance
probably reflects total atheroma plaque burden by 3D IVUS
reconstruction.
1.4.3 Endogenous t-PA and Endothelial Dysfunction
Whilst endothelial-dependent vasomotion is an important measure of cell
function, Newby and co-workers, described an in vivo model to measure
endothelial derived tissue plasminogen activator (t-PA) release, in the
assessment of the fibrinolytic capacity of the human forearm, using the
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Furthermore a reduction in t-PA release was demonstrated after inducing
experimental 'endothelial dysfunction' with nitric oxide synthase
inhibition (Newby et al 1998).
Interestingly, the endothelium-dependent vasodilator acetylcholine does
not induce t-PA release despite an increase in forearm blood flow (Brown
et al 1999). Endothelial fibrinolytic dysfunction, as manifest by an
impairment of endothelial t-PA release, appears to be a feature of cigarette
smoking and atherosclerosis (Newby et al 1999) but not
hypercholesterolaemia or subsequent lipid lowering therapy (Newby et al
2002). This is in contrast to endothelial function as assessed by
vasomotion following lipid-lowering therapy (Treasure et al 1995;
Anderson et al 1995). This would indicate that endothelial dysfunction can
be manifest in separate distinct pathways depending upon the nature of the
insult.
1.4.4 Coronary Artery Remodelling and Endothelial Function
The variable response of coronary arteries to endothelium-dependent
vasodilatation may be largely caused by the extent of lccal plaque load and
at what stage a given segment is in the remodelling process. Results based
on quantitative angiography define the atherosclerotic plaque load poorly
and do not take account of coronary remodelling. In effect, the relationship
between the degree of endothelial dysfunction and the remodelling process
in coronary arteries is not well-defined.
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1.5 Pulse Wave Analysis
The arterial pressure waveform alters with progression down the arterial
tree. This is due to local variations in vascular stiffness as well as
superimposition of the reflected pressure waveform (O'Rourke et al 1993).
The latter phenomenon occurs when the anterograde pressure wavefront
encounters the main points of impedance mismatch, such as the transition
from small to resistance arteries. This causes a reflected pressure
waveform to return to the central arteries and aorta in diastole, thereby
enhancing coronary perfusion pressure. Progressive arterial stiffening, as
occurs with ageing, causes an increase in the aortic pulse pressure due to
the combination of local aortic stiffness and an increase in both pulse wave
velocity and wave reflection. These stiffness-related effects produce an
increase in central aortic pressure and cardiac afterload, and a reduction in
coronary perfusion pressure due to the movement of the reflected wave
into systole (Nichols et al 1990; London et al 1990).
1.5.1 Arterial Stiffness and Cardiovascular Risk
Arterial stiffness increases with age (Avolio et al 1983), hypertension
(Nichols et al 1990), and in subjects with diabetes mellitus (Lehmann et al
1992), atherosclerosis (Wada et al 1994) and end-stage renal disease
(London et al 1990). An increase in arterial stiffness may have several
important consequences. Elevation of central aortic pressure promotes the
development of left ventricular hypertrophy (Lakatta et al 1990; Gatzka et
al 1998) and is associated with an increase in mortality (Levy et al 1990).
Stiffness of both the common carotid aorta and abdominal aorta has been
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found to progressively increase with 1, 2 and 3 vessel coronary artery
disease and in subjects with previous myocardial infarction (Hirai et al
1989).
Increased pulse pressure augments atherogenesis in primate models (Lyon
et al 1987) and may increase the likelihood of atherosclerotic plaque
rupture in humans (Cheng et al 1993). Moreover, in clinical studies,
elevations in pulse pressure and aortic stiffness are associated with an
increase in the future risk of coronary events (Mitchell et al 1997; Blacher
et al 1998; Gatzka et al 1998; Lehmann et al 1998) and overall mortality
(Benetos et al 1998; Domanski et al 1999; Blacher et al 1999).
1.5.2 Applanation Tonometry
The peripheral pulse pressure waveform (pulse wave analysis) and the
velocity of its propagation through the arterial tree (pulse wave velocity)
can be determined non-invasively using a technique called applanation
tonometry (O'Rourke et al 1996, Kelly et al 1989). Arterial stiffness
creates increased pulse wave velocity and the systolic peak is augmented
in view of the early reflection of the pressure wave from the periphery
(Latham et al 1985, O'Rourke et al 1993). A central aortic waveform is
derived from the peripheral waveform using a validated transfer function
(Karamanoglu et al 1993, O'Rourke et al 1995) (Figure 1.3) Surrogate
markers of atherosclerosis have been associated with increased pulse wave
velocity, namely the aortic calcification index (Blacher et al 2001), carotid
intima-medial thickness (Taniwaki et al 1999) and the ankle/brachial
systolic pressure index (Duprez et al 2001). No studies to date have been
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performed using applanation tonometry combined with intravascular
ultrasound of the coronary arteries in vivo in man, to investigate the
relationship between coronary plaque burden and systemic arterial
stiffness.
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Figure 1.3 A Central Aortic Pressure Waveform
The difference between the two systolic peaks, P, and P2 (AP), define the
augmentation index which is expressed as a percentage of the pulse
pressure (PP). The ejection duration is defined as the time from the foot of




The aims of the thesis were the following in patients with coronary artery
disease:
• to characterise and to identify the predominant plaque type in vivo
using unprocessed radio-frequency (RF) intravascular ultrasound
backscatter, in remodelled segments of human atherosclerotic coronary
arteries (Chapter 3).
• to examine the relationship between invasive measures of coronary
artery plaque volume using intravascular ultrasound and non-invasive
measures of arterial stiffness using applanation tonometry (Chapter 4).
• to establish the relationship between the volume of proximal coronary
artery atheroma, the presence of associated risk factors and local
coronary and endothelial function (Chapter 5).
• to assess whether the pattern of vascular remodelling influences the




In defining the aims of the thesis, several related hypotheses were
generated and are as follows:
• Positively remodelled segments have a greater proportion of lipid-rich
plaque than negatively remodelled segments.
• Coronary artery plaque load correlates positively with aortic stiffness
as measured by applanation tonometry.
• The extent of coronary atheroma will influence the vascular /
endothelial response.
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2.1 Introduction
Coronary angiography is limited both with respect to image quality and the
inability to examine the arterial wall directly. Intravascular ultrasound, in
particular, allows a more detailed functional and morphological assessment
of the epicardial coronary circulation. The coronary Doppler flow wire
provides a further means of assessing the coronary flow response.
Applanation tonometry and pulse wave analysis provide a means of
assessing arterial stiffness non-invasively.
Subselective intracoronary infusions have the advantage of assessing the
heart and coronary circulation in relative isolation without invoking
systemic effects. This is particularly important for the assessment of
cardiac and coronary function which is heavily dependent on changes in
the systemic vasculature and the haemodynamic status. In addition,
relatively high doses of investigational agent can be administered locally




All studies were undertaken in accordance with the Declaration ofHelsinki
(1989) of the World Medical Association and with the approval of the
Lothian Research Ethics Committee. The written informed consent of each





During the motorised IVUS pullback (Boston Scientific Corporation,
USA), a full frame of RF data was collected once per cardiac cycle by
ECG triggering, with a full frame made up of 256 radial scan lines,
corresponding to 360 degree rotation of the transducer. Each scan line was
digitised at a rate of 250 Msamples/s for a depth of approximately 6 mm
resulting in 2048 samples per line. Data was captured at 8-bit amplitude
resolution by an ADC card (GageApplied CS8500, Canada) installed in a
personal computer.
Frames of RE data were demodulated and scan-converted to produce
images equivalent to the standard IVUS video images (Research Systems
Inc., Boulder, CO, USA). These images were used to select frames of
interest, corresponding to the matched frame on s-VHS tape. Selected
frames had their regions of plaque marked out manually by tracing an
inner and an outer contour line on the scan-converted image.
The unprocessed RF data corresponding to the selected plaque regions
were divided into smaller regions of interest (ROI) of size 64 samples by 5
scan-lines, with an overlap of 16 samples and 2 scan-lines. Each 5-line
ROI was analysed by taking a Fourier transformation of each scan-line and
averaging over the 5 scan-lines. The resultant power spectrum was
normalised to the power spectrum obtained from the plane glass reflector
that measures the frequency response of the system and allows a suitable
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correction to be made to the ROI data for the response of the transducer-
machine combination (Spencer et al, 1997; Watson et al, 2000).
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2.4 Pulse Wave Analysis
2.4.1 Applanation Tonometry
With the subject lying supine, blood pressure was measured twice using an
Omron automated sphygmomanometer (HEM-705CP; Omron
Corporation, Japan) and the mean taken. Pulse wave analysis and velocity
were determined by applanation tonometry using a high-fidelity
micromanometer (SPC-301; Millar Instruments, TX, USA) and the
Sphygmocor™ system (Sphygmocor BPAS; PWV Medical, Sydney,
Australia). Triplicate pulse pressure waveforms were recorded from the
radial, femoral and carotid arteries and gated to the R wave of the
electrocardiogram. Pulse pressure waveform transit times were determined
by calculating the time between the foot of the pressure wave and the
inflection point, which provides a measure of the timing of the reflected
wave (Mackenzie et al 2002). Separation of the pulse waveforms was
defined as the difference between the distances from the sternal notch to
the radial head, the inguinal ligament and the thyroid cartilage. Data were
recorded on-line and the tonometer was repositioned to maximise the
quality of the trace and to minimise artefact. All measurements were made
in duplicate and mean values used in subsequent data analysis. Systolic
and diastolic variability during recordings in excess of 5% were excluded
and the measurement repeated.
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2.5 Intracoronary Ultrasound
2.5.1 Coronary Artery Cannulation
Following diagnostic coronary angiography, patients with left main stem
disease or a minimal luminal diameter of <2 mm in the index epicardial
coronary artery were excluded because of the potential for the IVUS
catheter to impede anterograde coronary blood flow. A non-tortuous, non-
branching segment of artery with a reference luminal diameter of □ 3.0 mm
and luminal irregularity (diameter stenosis of (20-70%) was then identified
for IVUS assessment. All patients received 5,000 IU of intravenous
heparin and, through an 8 F haemostatic sheath (Cordis®, Cordis Europa
N.V., Roden, The Netherlands), the left and right coronary arteries were
cannulated with a 7 F guide catheter (Cordis®).
2.5.2 Morphometric Assessment: Intravascular Ultrasound
Following insertion of a 0.014 inch 12.5 MHz Doppler wire (Flowire™,
Endosonics, Rancho Cordova, CA), across the arterial segment under
study, a 3.2 F Ultracross™ 30 MHz IVUS imaging catheter (Boston
Scientific Corporation, Maple Grove, MN) was advanced over the Doppler
wire. At the time of the IVUS catheter insertion, an intracoronary bolus of
200 pg glyceryl trinitrate was delivered through the guide catheter. The
imaging probe was retracted within the imaging catheter sheath at 0.5
mm/s using a motorised pullback device (Boston Scientific Corp.). All





Vessel cross-sectional area was measured by computer-assisted
planimetry, identifying the border between the hypo-echoic media (low
collagen content) and the echoreflective adventitia (high collagen content).
Lumen area was defined by planimetry of the lumen-intima interface. In
the calculations of intimal area, the media is incorporated because it can
not always be distinguished separately from the external elastic lamina
which lends itself to a reliable boundary for planimetry (Von Birgelen et al
1996). This does not have major implications for calculation of plaque area
as the media constitutes only a small fraction of the total area (200 pm in
thickness). Thus, the cross sectional area of intima + media (or plaque
area) represents the two-dimensional measurement of atheroma.
Plaque Area = Vessel CSA - Lumen CSA
Three-Dimensional Assessment
Three-dimensional computerised reconstruction of the two-dimensional
IVUS images was performed using the Toltec™ system (TomTec GmbH,
Munich, Germany). This provides frame-by-frame measurements of
vessel, lumen and plaque area along with total vessel, lumen and plaque
volumes. The proximal atheromatous plaque volume was calculated using
a well-validated edge detection algorithm (Von Birgelen et al, 1996; Von
Birgelen et al, 1997). Two longitudinal images were automatically
reconstructed with contours corresponding to lumen-intima and media-
adventitia interfaces. These were checked visually and corrected manually
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if necessary. Subsequent contour detection of the planar images was
performed with the axial location indicated by a cursor. This was used to
scroll through each image with any necessary manual correction. The
plaque area was defined as the region between the lumen border and the
echogenic interface of the external elastic lamina as previously described
(Di Mario et al, 1998; Von Birgelen et al, 1996). Intraobserver variability
in plaque volume acquired from a motorized pullback has previously been
reported with a mean (SD) of-0.3 ±1.0 % (Von Birgelen et al, 1996).
Volume measurements of the lumen, total vessel and plaque were
calculated with the adaptation of Simpson's rule:
N
Volume =X cross sectional area I * H
1=1
Where N is the number of images and H is the thickness of each slice.
2.5.4 Intracoronary Drug Infusion
The IVUS imaging catheter was positioned at the index segment. Selective
coronary artery drug infusion was attained by infusion through the flush
port of the IVUS catheter [Schwarzacher et al 2000]. The Doppler guide
wire was retracted to the tip of the imaging catheter (to be as close to the
IVUS image as possible) and maintained in a stable position by the short
monorail segment of the IVUS catheter (Schwarzacher et al 2000; Newby
et al 2000). All drugs were given as 2 ml boluses, followed by a 2 ml 0.9%
saline flush via the guide catheter (Newby et al 2000). The IVUS images
and Doppler ultrasound were recorded simultaneously to allow the
measurement of luminal area and coronary blood flow velocity for two
minutes following each drug bolus. The average peak velocity of the
Doppler signal was recorded onto S-VHS tape using the Flomap™
(Cardiometrics, Endosonics, Rancho Cordova, CA) Doppler velocimeter.
2.5.5 Coronary Compliance
IVUS permits real-time visualisation of coronary arteries. With cross-
sectional imaging, this permits measurement of vessel area and the phasic
changes in systole (when the vessel expands) and diastole. The images
were gated to the electrocardiogram and measurements were made at the
onset of the QRS complex (end-diastole) and the offset of the T-wave
(end-systole). Absolute compliance was determined from the resultant
pressure changes:
Absolute Compliance = (dA/dP) * 10
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where dA and dP represented change in total vessel area and coronary
pressure during one cardiac cycle.
Normalised Compliance corrects for vessel area differences:
Normalised Compliance = ([dA/AUiastole]/dP) mmHg1 * 103
To eliminate the influence of varying systemic blood pressure, a stiffness
index (13) is derived by normalising the dimension change to the diastolic
mean diameter (Nakatani et al, 1995):
Stiffness Index (13) = [Ln(SBP/DBP]/(dD/diastolic mean diameter)
Here, the systolic and diastolic mean diameters are calculated from those
areas with the assumption that the cross section was circular, hence,
diameter = [2 * (area/Tl)"2], where n=3.142
2.5.6 Coronary Blood Flow Measurement
The coronary artery cross-sectional area was measured using computerised
planimetry (Clearview™, Boston Scientific Inc) of the IVUS vessel
luminal area. The images were gated to the electrocardiogram and
measurements were made at the onset of the QRS complex. Blood flow
velocity was determined using average peak velocity of the Doppler signal
(Flowmap™ (Cardiometrics, Endosonics). Blood flow in the index
coronary artery was defined according to Doucette and co-workers as
[Doucette et al 1992]:
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Coronary blood flow (mL/min) = CSA * APV * 60
2 100
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3.1 Abstract
We aimed to characterise and to identify the predominant plaque type in
vivo using unprocessed radio-frequency (RF) intravascular ultrasound
backscatter, in remodelled segments of human atherosclerotic coronary
arteries. 16 remodelled segments (9 positive, 7 negative) were identified
using a 30 MHz IVUS scanner in-vivo. Spectral parameters (maximum
power, mean power, minimum power and power at 30 MHz) were
calculated and applied to a previous histologically validated classification
scheme. Plaque type was characterised as fibrous, calcified or lipid rich.
Positively remodelled segments had a larger vessel area (16.5±1.1 mm2 vs.
8.7+0.9 mm2, p<0.01) and plaque area (7.3±1.1 mm2 vs. 4.4±0.8 mm2,
p=0.05) than negatively remodelled segments. Both positive and
negatively remodelled segments had a greater percentage of fibrous plaque
(p<0.01) than calcified or lipid rich plaque. Comparing positively and
negatively remodelled segments, there was no significant difference
between the proportion of fibrous, calcified and lipid rich plaque. We have
been able to characterise and to identify plaque composition in vivo in
human atherosclerotic coronary arteries. Our data suggest that remodelled
segments are predominantly composed of fibrous plaque although plaque
composition is similar irrespective of the remodelling type.
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3.2 Introduction
Coronary artery remodelling describes the response of the arterial wall to
the presence of atherosclerotic plaque. In many cases the arterial wall
expands (positive remodelling) to accommodate the developing plaque to
reduce the encroachment on the lumen (Glagov et al 1987; Zarins et al
1988; McPherson et al 1991; Clarkson et al 1994). However there may be
shrinkage of the arterial wall (negative remodelling) in the presence of
atherosclerotic plaque with resultant luminal narrowing (Pasterkamp et al
1995; Nishioka et al 1996; Mintz et al 1997). Intravascular ultrasound
(IVUS) can provide reliable measurements of vessel dimensions and is
superior to coronary angiography in assessment of coronary artery
remodelling (von Birgelen et al 1996).
It has been suggested that discreet coronary artery lesions only become
apparent angiographically when the accumulation of plaque above a
threshold of 40% of total vessel area overcomes the ability of the vessel to
expand any further (Kakuta et al 1989; Post et al 1994; Currier et al 1995).
The inability of angiography to detect this occult disease is due to the
presence of positive remodelling and the diffuse nature of disease
throughout the entire vessel length in many patients. Furthermore,
important pathological features are not demonstrated by angiography
including plaque composition and the presence of a lipid-rich core, which
may indicate plaque stability or vulnerability. As a result, the degree of
luminal stenosis has been shown to be a weak indicator as to whether
plaque will eventually cause a myocardial infarction (Falk et al 1995).
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Plaque rupture has been shown to occur at sites where vessels show a
greater degree of positive remodelling than seen in stable lesions
(Schwarzacher et al 1998; Jeremias et al 2000). In a detailed histological
study, immunohistochemical staining of post mortem atherosclerotic
arteries demonstrated more markers of plaque vulnerability (increased
macrophages and lymphocytes, less collagen and smooth muscle cells) in
sections with a larger plaque to vessel area, i.e. positively remodelled
vessels (Pasterkamp et al 1998).
The unprocessed radio-frequency (RF) signal from ultrasound scanners is
not subject to operator-dependent settings or to machine-dependent
processing, and allows use of frequency-domain techniques (Urbani et al
1993; Spencer et al 1997), and hence may provide a more accurate means
of characterizing plaque in coronary artery remodelled segments than
previous visual and videodensitometric analysis of a grey scale level
(Gussenhoven et al 1989; Siegel et al 1992; Di Mario et al 1992; Peters et
al 1994; Rasheed et al 1995).
Plaque characterization using spectral features from IVUS images has been
described in both coronary arteries (Dixon et al 1997; Spencer et al 1997;
Moore et al 1998; Watson et al 2000; Nair et al 2002) and carotid arteries
(Noritomi et al 1997a, 1997b). Watson et al selected 299 regions-of-
interest (ROI) from eight post-mortem coronary arteries using a 30MHz
IVUS scanner. Predominant plaque composition of the vessel wall was
identified by routine histology and staining. A suture needle inserted in the
vessel wall throughout the IVUS pullback showed clearly on the IVUS
image and allowed alignment of the IVUS data with histology. With RF
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analysis in terms of spectral features, 86% of coronary plaque was
correctly classified into one of 3 categories (mixed fibrous tissue, lipid
pool and calcified plaque) (Watson et al 2000).
The aim of the present study was to characterize the predominant plaque





Ten patients (8 male) aged 55 to 68 years with angiographic evidence of
mild to moderate coronary artery disease were recruited at the time of
coronary angiography in two centres (Royal Infirmary and Western
General Hospital, Edinburgh, UK). Patients were excluded if they had
severe left main stem disease, left ventricular hypertrophy or significant
concurrent illness. The study was undertaken with the approval of the
local research ethics committee, in accordance with the Declaration of
Helsinki, and the written informed consent of each subject.
3.3.2 Study Protocol
All patients discontinued their medication on the study day, attended
fasted and underwent diagnostic coronary angiography. Standard
diagnostic images were taken using the Judkin's technique with a non-
ionic contrast agent (Niopam™ 340, MERCK Pharmaceuticals, Middlesex,
UK). A non-tortuous, non-branching segment of artery with a reference
luminal diameter of 3.0 mm and luminal irregularity (diameter stenosis of
up to 70%) was then identified for IVUS assessment.
A 7 French guiding catheter was used to cannulate the left or right
coronary artery. Following a 5,000 IU intravenous bolus of heparin (Leo
Laboratories Ltd., Princes Risborough, UK) and 200pg intracoronary bolus
of nitroglycerin (Nitrocine1M, SCWARZ Pharma Ltd, Chesham, UK), a 3.2
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F Ultracross™ 30 MHz IVUS imaging catheter (Atlantis SCIMED®,
Boston Scientific Corporation, Maple Grove, MN) was advanced into the
coronary artery. The IVUS examination of the proximal artery was
performed at 0.5 mm/s using a motorized pullback device (Boston
Scientific Corporation). All IVUS images were recorded on high fidelity s-
VHS videotape for later off-line quantitative analysis. Subsequent three-
dimensional computerized reconstruction of the two-dimensional IVUS
images was performed using the TomTec™ system (TomTec GmbH,
Munich, Germany).
Assessment ofRemodelled Segments
During the automated pullback, potential regions of interest (remodelled
segments) were identified. Segments were selected for inclusion in the
study if there was optimal image quality without rotational, angular or
image artifacts; clear demarcation of the endoluminal and the external
elastic laminal borders; and calcification of less than 180 degrees.
Segment remodelling was defined according to existing criteria based on
the total vessel area (external elastic laminal border) at the index site
relative to normal or near-normal proximal and distal reference segments
(Jeremias et al 2000). This enabled classification of the remodelled
segment by calculating relative total vessel area - the ratio of the total
vessel area at index segment to the mean of total vessel area at proximal
and distal reference segments. Categorization of segments was defined as
follows: positively remodelled segments with a ratio of >1.05 and
negatively remodelled segments with a ratio of <0.95 (Jeremias et al 2000)
(Figure 3.1).
3.3.3 Data Analysis
Analysis of the IVUS data was performed using software written in IDL
(Research Systems Inc., Boulder, CO, USA). Frames of RF data were
demodulated and scan-converted to produce images equivalent to the
standard IVUS video images. These images were used to select frames of
interest, corresponding to the matched frame on s-VHS tape. Selected
frames had their regions of plaque marked out manually by tracing an
inner and an outer contour line on the scan-converted image.
The unprocessed RF data corresponding to the selected plaque regions
were divided into smaller regions of interest (ROI) of size 64 samples by 5
scan-lines, with an overlap of 16 samples and 2 scan-lines. Each 5-line
ROI was analysed by taking a Fourier transformation of each scan-line and
averaging over the 5 scan-lines. The resultant power spectrum was
normalised to the power spectrum obtained from the plane glass reflector
that measures the frequency response of the system and allows a suitable
correction to be made to the ROI data for the response of the transducer-
machine combination (Spencer et al, 1997; Watson et al, 2000).
Classification
Features describing the normalised power spectrum were selected and fed
into a minimum-distance classification scheme. The four selected features
were the mean power over the (18-40) MHz bandwidth of the transducer;
the maximum power over the bandwidth; the spectral slope over the
bandwidth; and the intercept of the spectral slope with the 0-Hz axis. The
Mahalanobis distance was used as the distance metric, and the reference
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data used was that obtained from an earlier ex vivo study (Watson et al
2000).
Each ROI was classified into one of fibrous, calcified or lipid rich plaques.
The total area of fibrous, calcified or lipid in the selected plaque region
was calculated. The relative contribution of fibrous, calcified and lipid rich
plaque as a percentage of the overall plaque area (as defined by total vessel
area - lumen area) was also calculated
3.3.4 Statistical Analysis
All results are expressed as mean +/- standard error of the mean.
Continuous variables were analysed using the two-tailed Students Mest.
Probability (p) values <0.05 were considered statistically significant.
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3.4 Results
RF data was acquired from 10 patients involving 16 remodelled segments
(9 positively and 7 negatively remodelled).
Positively remodelled segments had a larger total vessel area (16.511.1
mm2 vs. 8.710.9 mm2, p<0.01) and plaque area (7.3+1.1 mm2 vs. 4.410.8
mm , p=0.05) than negatively remodelled segments. Both positively and
negatively remodelled segments had a greater percentage of fibrous plaque
(92% and 80% respectively) than calcified (7% and 6%) or lipid rich (8%
and 30%) plaque. Comparing positively and negatively remodelled
segments, there was no significant difference between the proportion of
fibrous, calcified and lipid rich subtypes.
3.5 Discussion
In this study using spectral features of IVUS signals, we have found that
fibrous plaques predominate and that there appears to be no difference in
plaque characteristics between positively and negatively remodelled
coronary artery segments, suggesting plaque stability is similar in both
remodelled types.
Positive remodelled segments have been found to be associated with
unstable coronary syndromes (Schwarzacher S et al 1998; Jeremias et al
2000), though our findings in this small study suggest that this is
independent of plaque type. Positive remodelled segments were found to
have a larger plaque burden that may be a factor in unstable lesions in
addition to other pathophysiological mechanisms such as inflammation,
shear stress and vascular compliance. We have however only studied
patients with stable coronary artery disease and our findings may not be
applicable in patients with acute coronary syndromes.
Grey-scale interpretation limits the IVUS assessment of heterogeneous
plaque commonly found in unstable lesions. Combined with spectral
analysis, the ability to characterise plaque composition accurately may
have important implications in both the identification and treatment of
vulnerable plaques. This study allowed in vivo assessment of quantitative
plaque composition. Previous ex vivo studies with histological validation
have revealed that spectral analysis of IVUS RF data can reveal
information regarding plaque characteristics (Watson et al 1997; Spencer
et al 1997; Moore et al 1998). RF data provide multiple parameters and,
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with classification trees, prediction can be improved by autoregressive
classification schemes as opposed to classical Fourier transformations
(Nair et al 2002).
Our study classified each ROI into 3 broad sub-groups: calcified, fibrous
or lipid rich (Watson et al, 2000). The study by Nair and colleagues has
also reported a high accuracy of identifying calcified necrotic and
fibrolipid areas ex vivo with histological validation (Nair et al, 2002).
Watson et al previously collected the reference ex vivc data on a different
IVUS system (HP SONOS) from that used in the present in vivo study
(Boston Scientific CVIS). However, the calibration technique should
correct for any differences between the two systems. The reference data
were also obtained by scanning vessels through saline whereas the present
remodelling data were obtained in vivo and hence through blood. The
effects of blood on the backscatter information have not yet been
characterized.
There exists a tissue-dependent variation of backscatter with angle of
incidence. The reference data were collected with the catheter located
approximately centrally in the vessel, where any angle-dependent effects
would be small. The difficulty of controlling the catheter location during in
vivo data collection means that some angle-dependent effects cannot be
excluded.
The effects of attenuation due to overlying tissue have not been considered
here, although the analysed sites were close to the surface of the vessel.
Spencer et al (Spencer et al 1997) investigated the variation of spectral
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features with depth (i.e. distance into the vessel wall) up to 1.5mm and
found that variations due to tissue characteristics were considerably
greater than any visible variation with depth.
Although the present data were collected on a different system and under
different conditions from that of the classifier reference data, the plane-
glass reflector data should in principle be able to correct for any system-
dependent effects.
This study was conducted in the necessary clinical setting of patients with
a combination of risk factors and concomitant therapies undergoing
diagnostic coronary angiography. The small sample size means that this
study lacked sufficient power to address the influence of the individual
variables associated with coronary artery disease. Remodelled sites were
limited to 1 or 2 per patient in view of procedure duration and single
vessel data acquisition. Multiple sites per patient ideally would have been
required to help assess the influence of both local and patient factors on
determining the type of remodelling. Our findings may not be
representative of all coronary artery atherosclerotic plaques. Heavily
calcified lesions were excluded because the resultant acoustic shadow
makes it very difficult to measure vessel areas and to characterise the
deeper plaque. In addition, small vessels and significant stenoses were also




In this small in vivo study, using the novel technique of using unprocessed
RF intravascular ultrasound backscatter, remodelled segments were
identified by RF analysis to be predominantly composed of fibrous plaque.
Plaque composition was similar irrespective of whether there was positive
or negative arterial remodelling.
69
























Fibrous (%) 92.1±1.6 80.4±6.5 NS
Calcified (%) 6.6±1.4 5.7i0.6 NS
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4.1 Abstract
Arterial stiffness is an emerging major risk factor for cardiovascular
morbidity and mortality. The aim of the present study was to assess if
coronary artery plaque load correlates with non-invasive measures of
arterial stiffness. In 35 patients (61±2 years), coronary artery plaque
burden was assessed using a 30 MHz intravascular ultrasound catheter
during an automated pullback. Proximal coronary artery plaque volume
was determined using a validated edge detection algorithm following
three-dimensional computerised reconstruction. Central arterial stiffness
was assessed in each patient using applanation tonometry to radial, carotid
and femoral pulses, with derivation of aortic pressure augmentation and
pulse wave velocity using pulse wave analysis. Proximal coronary arterial
plaque volume was 5.9±0.6 mm3 per mm of vessel. Plaque volume
positively correlated with carotid-radial pulse wave velocity (r=0.47,
p=0.008) and appeared to correlate with carotid-femoral pulse wave
velocity (r=0.34, p=0.07). Aortic augmentation (r=0.24, p=0.16),
augmentation index (r=0.3, p=0.08), and pulse pressure (r=0.22, p=0.2)
did not significantly correlate with proximal coronary artery plaque
volume. Non-invasive measures of pulse wave velocity correlate with the
extent of coronary artery plaque volume and may be a useful non-invasive
surrogate marker for the extent of coronary atherosclerosis. Our findings
are consistent with the suggestion that central aortic stiffness may promote
the development of coronary atherosclerosis and ischaemic heart disease.
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4.2 Introduction
The arterial pressure waveform alters with progression down the arterial
tree. This is due to local variations in vascular stiffness as well as
superimposition of the reflected pressure waveform (O'Rourke et al 1993).
The latter phenomenon occurs when the anterograde pressure wavefront
encounters the main points of impedance mismatch, such as the transition
from small to resistance arteries. This causes a reflected pressure
waveform to return to the central arteries and aorta in diastole, thereby
enhancing coronary perfusion pressure. Progressive arterial stiffening, as
occurs with ageing, causes an increase in the aortic pulse pressure due to
the combination of local aortic stiffness and an increase in both pulse
wave velocity and wave reflection. These stiffness-related effects produce
an increase in central aortic pressure and cardiac afterload, and a reduction
in coronary perfusion pressure due to the movement of the reflected wave
into systole (Nichols et al 1990; London et al 1990).
An increase in arterial stiffness may have several important consequences.
Elevation of central aortic pressure promotes the development of left
ventricular hypertrophy (Lakatta et al 1990; Garzka et al 1998) and is
associated with an increase in mortality (Levy et al 1990). Increased pulse
pressure, a measure of arterial stiffness, augments atherogenesis in primate
models (Lyon et al 1987) and may increase the likelihood of
atherosclerotic plaque rupture in humans (Cheng et al 1993). Moreover, in
clinical studies, elevations in pulse pressure and aortic stiffness are
associated with an increase in the future risk of coronary event events
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(Mitchell et al 1997; Blacher et al 1998; Gatzka et al 1998; Lehmann et al
1998) and overall mortality (Benetos A et al 1998; Domanski et al 1999;
Blacher et al 1999).
The peripheral pulse pressure waveform (pulse wave analysis) and the
velocity of its propagation through the arterial tree (pulse wave velocity)
can be determined non-invasively using applanation tonometry (O'Rourke
et al 1996; Kelly et al 1989). This simple, reproducible and well-validated
technique (Karamanoglu et al 1993; Chen et al 1997; Fetics et al 1999;
Wilkinson et al 1998) of assessing central arterial stiffness has widespread
clinical and research applications (Mackenzie et al 2002).
Surrogate markers of atherosclerosis have been associated with increased
pulse wave velocity (van Popele et al 2001). However, the relationship
between arterial stiffness and coronary artery plaque load is currently
unknown. The quantitation of coronary artery plaque load is difficult
because standard quantitative coronary angiography has several inherent
limitations and inaccuracies that occur because it can only assess the
arterial lumen and is unable to take account of arterial remodelling. In
contrast, intravascular ultrasound (IVUS) permits an accurate and
reproducible quantification of coronary atherosclerotic plaque in man (von
Birgelen et al 1996).
The aim of the present study was therefore to examine the relationship
between invasive measures of coronary artery plaque volume using





Thirty-five patients with angiographically normal coronary arteries or mild
to moderate coronary artery disease were recruited at the time of elective
coronary angiography in two centres (Royal Infirmary and Western
General Hospital, Edinburgh, UK). Patients were excluded if they had
severe left main stem disease, left ventricular hypertrophy or significant
concurrent illness. All patients had their coronary risk factors determined
by standard clinical criteria. Hypercholesterolemia was defined as a fasting
total cholesterol >190 mg/dL (>5.0 mmol/L) prior to initiation of lipid
lowering therapy. The study was undertaken with the approval of the local
research ethics committee, in accordance with the Declaration of Helsinki,
and the written informed consent of each subject.
4.3.2 Study Protocol
Coronary Angiography
All patients discontinued their medication on the study day, attended fasted
and underwent diagnostic coronary angiography. Standard diagnostic
images were taken using the Judkin's technique with a non-ionic contrast
agent (Niopam™ 340, MERCK Pharmaceuticals, Middlesex, UK).
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Intravascular Ultrasound and Plaque Volume Assessment
A non-tortuous, non-branching segment of artery with a reference luminal
diameter of 3.0 mm and luminal irregularity (diameter stenosis of up to
70%) was identified for IVUS assessment. A 7 French guiding catheter
was used to intubate the left or right coronary artery. Following a 5,000 IU
intravenous bolus of heparin (Leo Laboratories Ltd., Princes Risborough,
UK) and 200 pg intracoronary bolus of nitroglycerin (Nitrocine™,
SCWARZ Pharma Ltd, Chesham, UK), a 3.2 F Ultracross™ 30 MHz
IVUS imaging catheter (Atlantis SCIMED®, Boston Scientific
Corporation, Maple Grove, MN) was advanced into the coronary artery on
an 0.014" guide-wire.
The IVUS examination of the proximal artery was performed at 0.5 mm/s
using a motorized pullback device (Boston Scientific Corporation). All
IVUS images were recorded on high fidelity s-VHS videotape for later off¬
line quantitative analysis. The plaque area was defined as the region
between the intima-lumen interface and the external elastic lamina (von
Birgelen et al 1996; Newby et al 2001). Subsequent three-dimensional
computerized reconstruction of the two-dimensional IVUS images was
performed using the TomTec™ system (TomTec GmbH, Munich,
Germany) with plaque volume derived from a well-validated edge
detection algorithm (von Birgelen et al 1996; Newby et al 2001). Plaque
volume was calculated per mm of coronary artery length.
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Pulse Wave Analysis
With the subject lying supine, blood pressure was measured twice using an
Omron automated sphygmomanometer (HEM-705CP; Omron
Corporation, Japan) and the mean taken. Pulse wave analysis and velocity
were determined by applanation tonometry using a high-fidelity
micromanometer (SPC-301; Millar Instruments, TX, USA) and the
Sphygmocor™ system (Sphygmocor BPAS; PWV Medical, Sydney,
Austrailia). Triplicate pulse pressure waveforms were recorded from the
radial, femoral and carotid arteries and gated to the R wave of the
electrocardiogram. Pulse pressure waveform transit times were determined
using the foot-to-foot methodology (Mackenzie et al 2002). Separation of
the pulse waveforms was defined as the difference between the distances
from the sternal notch to the radial head, the inguinal ligament and the
thyroid cartilage. Data were recorded on-line and the tonometer was
repositioned to maximise the quality of the trace and to minimise artefact.
All measurements were made in duplicate and mean values used in
subsequent data analysis. Systolic and diastolic variability during
recordings in excess of 5% were excluded and the measurement repeated.
After acquiring a series of consecutive waveforms, the mean peripheral
and central arterial waveforms were recorded and the augmentation index
(AIx) derived. The AIx was calculated as the difference between the first
and second peaks of the central aortic waveform expressed as a percentage
of the pulse pressure.
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4.3.3 Statistical Analysis
All results are expressed as mean ± standard error of the mean. Data were
analysed, where appropriate, using analysis of variance (ANOVA),





Thirty-five patients (26 male) were assessed with an average age of 61
years (range 46-78). Baseline characteristics are shown in Table 4.1. The
procedure was well tolerated and there were no significant adverse effects.
4.4.2 Plaque Volume
Following IVUS assessment, plaque was quantified in the left anterior
descending (28), right (3) and left circumflex (4) coronary arteries. The
mean length of vessel analysed was 32+lmm (range 7 - 40mm). Average
plaque volume was 5.9 ± 0.6 mm3 per mm of vessel (range 0.9 - 13.7
mm3/mm; Table 4.2). Plaque volume appeared to be lower in the female
subgroup but this was not statistically significant.
4.4.3 Pulse Wave Analysis
Pulse wave analysis of the study population is given in Table 4.3.
Coronary artery plaque volume correlated with carotid-radial pulse wave
velocity (r=0.47, p=0.008; Figure 4.1) with a trend in the relationship with
carotid-femoral pulse wave velocity (r=0.34, p=0.07). There was no
significant association between plaque volume and aortic augmentation
(r=0.24, p=0.16), augmentation index (r=0.3, p=0.08), and pulse pressure
(r=0.22, p=0.2). Carotid-radial pulse wave velocity was significantly
greater in males than females (8.4± 0.4ms"1 vs. 6.8± 0.4ms"1; p<0.001) and
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there was a trend towards a greater carotid-femoral pulse wave velocity
(9.4±0.4ms"' vs. S.StO.Sms"1; p=NS). There was no significant difference
in aortic augmentation, augmentation index and pulse pressure between
male and female subgroups (Table 4.2).
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4.5 Discussion
We have shown that the underlying coronary artery plaque burden
correlates with pulse wave velocity but not other measures of pulse wave
analysis. This association is likely to reflect the common aetiological
factors involved in the development of aortic and coronary atheroma.
However, our findings are also consistent with the suggestion that central
aortic stiffness may promote the development of coronary atherosclerosis
and ischaemic heart disease
Consistent with our findings, stiffness of both the thoracic aorta and
abdominal aorta progressively increases in patients with single, two and
three-vessel disease as well as those with previous myocardial infarction
(Hirai et al 1989). Interestingly, exercise stress testing in patients with
angiographic evidence ofmoderate coronary artery disease has also shown
a correlation between time to ischaemia and large artery stiffness as
assessed by carotid applanation tonometry (Kingwell et al 2002). This
suggests that aortic stiffness is not only associated with structural
atherosclerotic disease, but also the functional consequences.
It is now recognised that arterial stiffness is associated with both
cardiovascular risk (Benetos et al 1998, Mitchell et al 1997; Franklin et al
1999) and a strong predictor of myocardial infarction (Boutouyrie et al
2002). Our demonstration of an association between coronary artery
plaque volume and arterial stiffness raises questions of cause-and-effect.
Longitudinal studies would be necessary to document whether coronary
artery disease develops in subjects with increased arterial stiffness.
However, it is interesting to note that young children with
hypercholesterolaemia (Iannuzzi et al 1999; Aggoun et al 2000), marked
obesity (Tounian et al 2000) or low birth weight (Martin et al 2000) have
increased arterial stiffness at a young age before the development of
widespread atheroma.
Our study population had a combination of risk factors for coronary artery
disease that will contribute to arterial stiffness (Cockcroft et al 1991). 31
Hypercholesterolaemia is associated with endothelial dysfunction and
impaired endogenous nitric oxide release (Chowienczyk et al 1992; Stoes
et al 1995). Arterial stiffness is increased by both nitric oxide synthase
inhibition and hypercholesterolaemia (Iannuzzi et al 1999; Wilkinson et al
2002). Furthermore treatment with lipid lowering therapy improves
endothelial function and increases the bioavailability of nitric oxide (Stroes
et al 1995; Leung et al 1993). Thus, the association between coronary
artery plaque volume and aortic stiffness may, in part, reflect the common
aetiological factors that will inevitably exist in this clinical population.
Study Limitations
Because of ethical and technical considerations, we did not assess patients
with severe coronary artery disease, tight luminal stenoses and a very high
plaque load. Moreover, we assessed a single coronary artery segment and
we cannot be certain that this was representative of the entire coronary
circulation in each patient. However, intravascular ultrasound is a very
precise method of determining plaque load with excellent reproducibility
(von Birgelen et al 1996; Hagenaars et al 2000).
84
By necessity, many of the study patients were established on concomitant
medical therapy. Treatments such as P-adrenergic receptor blockade and
angiotensin-converting enzyme inhibition have been shown to influence
aortic stiffness (Ting et al 1991; Breithaupt-Grogler et al 1996). Whilst
such treatments may affect the functional aspects of arterial stiffness, the
structural component of arterial stiffness will be unaffected and we were
still able to demonstrate a significant association.
We did not find an association between other markers of arterial stiffness
and coronary plaque volume. However, this is likely to reflect a lack of
power as the overall trend was in the same direction for all measures.
Moreover, it is recognised that pulse wave velocity is one of the more
robust and sensitive measures of arterial stiffness and accounts for its
closer association (Mackenzie et al 2002).
Conclusions
The association between coronary artery plaque burden and pulse wave
velocity provides further evidence that central aortic stiffness may promote
the development of coronary atherosclerosis and ischaemic heart disease.
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Table 4.1 Baseline patient characteristics.
Number 35








Family history 10 (29%)




Calcium Antagonist 18 (51%)
Long-acting Nitrate 14 (40%)
Lipid Lowering Therapy 18(51%)
ACE Inhibition 3 (9%)
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Table 4.2 Pulse wave analysis and arterial stiffness in male and
female subgroups.
Male
Coronary plaque volume 6.6 ± 0.6
Carotid-radial velocity 8.4 ± 0.4
Carotid-femoral velocity 9.4 ± 0.2
Aortic augmentation 12 ± 1.7
Augmentation index 25 ± 1.9




6.8 ± 0.4* (ms1)
8.5 ± 0.5 (ms"')
15 ±2.9 (mmHg)
26 ±3.6 (%)
62 ± 6 (mmHg)
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68 ± 2 (/min)
145 ± 4 (mmHg)
79 ± 2 (mmHg)
62 ± 4 (mmHg)
135 + 4 (mmHg)
80 ± 2 (mmHg)
55 ± 3 (mmHg)
12 ± 2 (mmHg)
25 ± 2 (%)
865 ± 48 (mmHg/s)
152 + 5 Wood units
314+10 (ms)
8.0 ± 0.3 (m/s)
9.2 ± 0.4 (m/s)
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Figure 4.1 Correlation between coronary artery plaque volume
and carotid-radial (closed circles; upper panel, n=33) and carotid-
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Webb DJ, Fox KAA, Boon NA. Impaired coronary fibrinolytic capacity is
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5.1 Abstract
The objective of the study was to establish the relationship between the
volume of proximal coronary artery atheroma, the presence of associated
risk factors and the stimulated release of tissue plasminogen activator (t-
PA) from the heart. Following diagnostic coronary angiography in 25
patients, the left anterior descending artery (LAD) was instrumented and
the proximal LAD plaque volume was determined using intravascular
ultrasound (IVUS). Blood flow and fibrinolytic responses to selective
LAD infusion of saline, substance P (10-40 pmol/min) and sodium
nitroprusside (5-20 pg/min) were measured using intracoronary IVUS and
Doppler, combined with arterial and coronary sinus blood sampling. Mean
plaque burden was 5.5 ± 0.8 mm3 per mm of vessel (range 0.6-13.7). LAD
blood flow increased with both substance P and sodium nitroprusside
(p<0.001), although coronary sinus plasma t-PA antigen and activity
concentrations increased only during substance P infusion (p □ 0.006 for
both). There was a significant inverse correlation between the LAD plaque
burden and release of active t-PA (r=-0.61, p=0.003). Cigarette smoking,
but no other risk factor, was associated with an impairment of coronary
release of active t-PA (smokers, 42 ± 21 versus nonsmokers, 202 ±73
IU.min"1; p=0.01). We have found an association between both the
coronary atheromatous plaque burden and smoking habit with the acute
local fibrinolytic capacity of the heart. These important findings
potentially provide a direct link between endogenous fibrinolysis,
endothelial dysfunction and atherothrombosis.
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5.2 Introduction
The endothelium plays a vital role in the control of blood flow,
coagulation, fibrinolysis and inflammation. Consequently, the maintenance
and regulation of tissue perfusion critically depends upon the integrity of
endothelial function and the release of potent endothelium-derived factors.
Following the seminal work of Furchgott and Zawadski (Furchgott &
Zawadski 1980), it has been widely recognised that an array of mediators
can influence vascular tone through endothelium-dependent actions. There
is an extensive body of evidence to show that endothelium-dependent
vasomotion is abnormal in patients with atherosclerosis (Ludmer et al
1986) and its associated risk factors (Celermajer et al 1992; Chowienczyk
et al 1992; Celermajer et al 1996). However, whilst endothelium-
dependent vasomotion is an important indicator of endothelial cell
function, it is an indirect surrogate measure of the central
pathophysiological role of the endothelium in atherothrombosis.
Acute rupture or erosion of a coronary atheromatous plaque and
subsequent coronary artery thrombosis causes the majority of sudden
cardiac deaths and myocardial infarctions (Burke et al 1997; Davies 2000).
Small areas of denudation and thrombus deposition are a common finding
on the surface of atheromatous plaques and are usually sub-clinical
(Davies 2000). However, in the presence of an imbalance in the
fibrinolytic system, such microthrombi may propagate, ultimately leading
to arterial occlusion (Rosenberg & Aird 1999). Indeed, genetic murine
models indicate that t-PA deficiency is associated with myocardial
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necrosis and the development of regional wall motion abnormalities
(Christie et al 1999).
In the Northwick Park Heart Study (Meade et al 1993), low basal plasma
fibrinolytic activity was a leading determinant of the risk of sustaining a
myocardial infarction or sudden cardiac death in younger men. Moreover,
a reduction in exercise induced release of t-PA is associated with an
increased incidence ofmajor adverse cardiac events in patients with stable
angina pectoris (Held et al 1997). Recently, Rosenberg and Aird
(Rosenberg & Aird 1999) have postulated that vascular-bed-specific
defects in haemostasis exist, and that coronary thrombosis critically
depends on the local fibrinolytic balance. However, there have been no
clinical studies to date which have directly assessed the acute local
fibrinolytic capacity of the coronary vascular bed in patients with coronary
artery disease.
Using forearm venous occlusion plethysmography and the endothelium-
dependent agonist, substance P, we have recently developed and
characterised a novel model of assessing the acute release of endogenous t-
PA in vivo in man (Newby et al 1997b). This has enabled us to
demonstrate that cigarette smoking is associated with an impairment of
acute t-PA release (Newby et al 1999a) although this has yet to be
confirmed in the coronary circulation. The aims of the present study were:
first, to apply this approach to the coronary circulation and thereby
establish a method of assessing acute coronary t-PA release; second, to
determine the relationship between the extent of coronary artery atheroma,
quantified by intravascular ultrasound (IVUS), and the acute fibrinolytic
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capacity of the coronary vascular bed; and third, to determine if cigarette




Patients undergoing elective coronary angiography were recruited unless
they had significant aortic stenosis, severe left ventricular dysfunction or
recent (<3 months) myocardial infarction. Following angiography, patients
were excluded if they had significant left main stem disease or a minimal
luminal diameter of less than 2 mm in the proximal left anterior
descending coronary artery. All patients had their risk factor profile
determined by standard clinical criteria: smoking habit (current/ex-smoker
or non-smoker), family history of premature (male: <50 years, female: <55
years) coronary artery disease, and a history of hypertension (systolic
blood pressure >160 mmHg or diastolic blood pressure >90 mmHg on 3
or more occasions), diabetes mellitus (fasting blood glucose concentration
>7.8 mmol/L or >11.1 mmol/L 2 hours after 75 g glucose load) or
hypercholesterolaemia (total serum cholesterol concentration >5.0
mmol/L). Since many patients discontinued a regular smoking habit just
prior to angiography, current and ex-smokers were considered as a single
group. The study was undertaken with the approval of the local research
ethics committee and in accordance with the Declaration of Helsinki. The




All patients discontinued their medication on the study day, attended fasted
and underwent diagnostic coronary angiography at 08.00 h. Following
angiography, patients fulfilling the entry criteria were entered into the
study and received 5,000 IU of intravenous heparin. Cannulation of the
coronary sinus was established from the femoral vein using a preformed
specific 6 F catheter (modified Simmons Torcon NB catheter, HNB6.0-
NT-100-PW-2S-112393-BH) (Katritsis & Webb-Peploe 1997). To avoid
atrial blood mixing, the catheter was advanced, sometimes with the
assistance of a guide wire, deep into the ostium and beyond the posterior
interventricular vein. Stable and selective cannulation of the coronary sinus
was achieved in all but three subjects. Arterial samples were obtained
through an 8 F haemostatic sheath placed in the right femoral artery.
The left coronary artery was cannulated with a 7 F guiding catheter and a
0.014 inch 12.5 MHz Doppler wire (Flowire™, Cardiometrics,
Endosonics, Rancho Cordova, CA, USA) was passed into the left anterior
descending coronary artery. A 3.2 F Ultracross™ 20 MHz IVUS imaging
catheter (SCIMED®, Boston Scientific Corporation, MN, USA) was
advanced into the left anterior descending coronary artery over the guide
wire. The IVUS examination of the proximal artery was performed at 0.5
mm/s using a motorised pullback device (Boston Scientific Corp) whilst
recording the ultrasound images onto S-VHS tape using the Clearview™
ultrasonogram (Boston Scientific Corp). Following the pullback
examination, the IVUS imaging catheter was repositioned just distal to the
ostium of the left anterior descending artery. The Doppler guide wire was
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retracted to the tip of the imaging catheter and maintained in a stable
position by the short monorail segment of the IVUS catheter
[Schwarzacher et al 2000]. The average peak velocity of the Doppler
signal was recorded onto S-VHS tape using the Flomap™ (Cardiometrics)
Doppler velocimeter.
5.3.3 Drug Administration
Pharmaceutical-grade substance P (Clinalfa AG, Laufelfingen,
Switzerland), an endothelium and neurokinin type 1 receptor dependent
vasodilator [Newby et al 1999c], and sodium nitroprusside (David Bull
Laboratories, Warwick, U.K.), an endothelium independent vasodilator,
were administered following dissolution in saline (0.9%: Baxter
Healthcare Ltd, Thetford, UK). Five minute infusions were administered
using an IVAC PI000 syringe pump (IVAC Ltd, Basingstoke, UK) at 1
mL/min via the IVUS catheter flush port (Schwarzacher et al 2000). The
agents were given in the following order: saline, substance P 10 pmol/mL,
substance P 20 pmol/mL, substance P 40 pmol/mL, sodium nitroprusside 5
jag/mL and sodium nitroprusside 20 jag/mL. Due to limitations in
procedural time, the sodium nitroprusside responses were determined in 14
patients only.
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5.3.4 Measurement of Plaque Volume and Coronary Blood
Flow
Computerised three dimensional reconstructions of the proximal left
anterior descending coronary artery were performed off-line by a single
blinded operator using the TomTec computer system (Echoscan, TomTec
Imaging Systems, Unterschleissheim, Germany). The proximal
atheromatous plaque volume was calculated using a well validated edge
detection algorithm (von Birgelen et al 1996a; von Birgelen et al 1997).
The planar contours were checked by the operator and, if necessary, edited.
The plaque area was defined as the region between the luminal border and
the echogenic interface of the external elastic lamina as previously
described (Di Mario et al 1998; von Birgelen et al 1996b).
The left anterior descending coronary artery cross-sectional area was
measured using computerised planimetry (Clearview™, Boston Scientific
Inc) of the vessel lumen. The IVUS images were gated to the
electrocardiogram and measurements were made at the onset of the QRS
complex. Blood flow velocity was determined using average peak velocity
of the Doppler signal (Flopmap™, Cardiometrics). Blood flow in the left
anterior descending coronary artery was determined from the mean of five
measurements made in the final minute of each infusion period and was
defined as (Doucette et al 1992) Coronary blood flow (mL/min) =
CSA . APV . 60
2 100
where CSA = cross-sectional area (mm2) and APV = average peak velocity
(cm/s).
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5.3.5 Blood Sampling and Plasma Assays
Ten mL of arterial and coronary sinus blood were obtained simultaneously
at the end of each infusion period, collected into acidified buffered citrate
(Biopool® Stabilyte™, Umea, Sweden) and citrate (Monovette®, Sarstedt,
Numbrecht, Germany) tubes, and kept on ice before being centrifuged at
2,000 g for 30 minutes at 4°C. Platelet free plasma was decanted and
stored at -80°C before assay. Coronary sinus oxygen saturations were
determined at the end of each infusion period using an automated oximeter
(Oxicam™ 300, Watco Services, Basingstoke, UK).
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5.3.6 Data Analysis and Statistics
Coronary t-PA release was defined as the product of the left anterior
descending artery plasma flow (based on the haematocrit, Hct and the left
anterior descending coronary blood flow, CBF) and the plasma arterial ([t-
PA]Art) and coronary sinus ([t-PA]ven) concentration differences.
Coronary t-PA release = CBF x {1-Hct} x {[t-PA]yen -l>A]Art}
In order to compare vasomotor and fibrinolytic responses with proximal
atheromatous plaque volume, the area under the curve (AUC) was
calculated for each response: coronary blood flow, plasma arterial and
coronary sinus t-PA concentration differences, and estimated net t-PA
release.
Data were examined by analysis of variance (ANOVA) with repeated
measures, two tailed paired and unpaired Student's 7-test, and univariate
and multivariate regression analysis using StatView vb.0.1 (SAS Institute
Inc., Cary, North Carolina, USA). All results are expressed as mean ±




Baseline patient characteristics are shown in Table 5.1. In keeping with the
anticipated profile of patients undergoing coronary angiography, the study
population was predominantly middle-aged, male and had a combination
of risk factors. Throughout the study there were no significant changes in
heart rate, mean arterial pressure or haematocrit (0.40 ± 0.01).
5.4.1 Plaque Volume and Blood Flow Responses
The proximal 29 ± 1 mm of the left anterior descending coronary artery
were reconstructed and found to contain 160 ± 24 mm3 of atheromatous
plaque: a plaque burden of 5.5 ± 0.8 mm3 per mm of vessel (range, 0.6 to
13.7). There was a significant linear correlation between the plaque burden
and the serum total cholesterol: HDL-cholesterol ratio (r=0.55, p=0.004).
Left anterior descending coronary artery blood flow increased with both
substance P and sodium nitroprusside infusion (p<0.001, ANOVA; see
Table 5.2). There was a significant linear correlation between the
percentage increase in coronary sinus oxygen saturations and left anterior
descending coronary artery flow (r=0.46, p<0.001). However, there was no
correlation between the plaque burden and the AUC for the coronary blood
flow responses to substance P or sodium nitroprusside infusion. In
contrast, there was an association between the number of risk factors for
atherosclerosis and the coronary blood flow responses to substance P
(Figure 5.1: r=-0.42, p<0.05).
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5.4.2 Plasma Fibrinolytic Parameters
There was a significant rise in plasma t-PA antigen and activity
concentrations from the coronary sinus during substance P infusion (Table
5.2: ANOVA, p<0.001 and p<0.006 respectively) but not during sodium
nitroprusside infusion. There was a significant inverse correlation between
the plaque burden and the AUC for active t-PA release (Figure 5.2: r=-
0.61, p=0.003), and a trend for the AUC for t-PA antigen release (r=-0.34,
p=0.15). There was also an inverse linear correlation between the basal
coronary sinus plasma t-PA antigen concentration and the AUC for active
t-PA release (r=-0.58, p<0.005).
Ex- and current cigarette smokers had a higher basal plasma t-PA antigen
concentration and an impaired active t-PA response to substance P
infusion in comparison to non-smokers despite similar plasma PAI-1
concentrations and coronary arterial plaque burden (Table 5.2). Subgroup
analysis demonstrated that current smokers (n=4) had similar release of
active t-PA compared to ex-smokers (n=13): 49 ± 32 and 40 ± 28 IU/min
respectively. Hypercholesterolaemia, hypertension, diabetes mellitus and a
family history of premature coronary artery disease had no influence on t-
PA release.
There were no significant changes in plasma PAI-1 antigen and activity
concentrations throughout the study (Table 5.2). Basal coronary sinus
plasma PAI-1 antigen concentrations correlated positively with plaque
burden (r=0.47, p<0.03) and negatively with release of active t-PA (r=-
0.44, p=0.04).
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Multivariate regression analysis identified plaque burden and basal
coronary sinus t-PA antigen concentrations as the independent variables




For the first time, we have shown a direct relationship between both the
coronary atheromatous plaque burden and smoking habit with the acute
fibrinolytic capacity of the heart. These important findings suggest that
both atherosclerosis and smoking habit influence the local fibrinolytic
balance in the coronary circulation, and provide a direct link between
endothelial dysfunction, atherothrombosis and myocardial infarction.
The clinical importance of endogenous t-PA release is exemplified by the
high rate of spontaneous reperfusion in the infarct related artery after acute
myocardial infarction; occurring in one third of patients within the first 12
hours (Wood et al 1980; Armstrong et al 1989; Rentrop et al 1989).The
present study is the first to attempt directly to assess the acute release of t-
PA in the coronary circulation of patients with stable coronary artery
disease. Although thrombin and activated coagulation Factor X may be
more physiologically relevant to acute t-PA release than substance P, we
have used the latter because its vascular actions are endothelium-
dependent [Gross et al 1994] and its administration intra-arterially is safe
and well tolerated (Crossman et al 1989; Newby et al 1997a]). Using this
approach, we have been able to stimulate the fibrinolytic activity of the
coronary vascular bed and demonstrate that this response appears to be
sensitive to the presence of atheroma: a rapid decline in release of active t-
PA associated with an increasing plaque burden. This reduction in acute
fibrinolytic capacity appears to reflect both an impairment of acute t-PA
release and an elevation in plasma PAI-1 concentrations. The mechanisms
underlying this relationship remain to be established but are likely to
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involve chronic endothelial cell injury and an impairment of the L-
arginine:nitric oxide pathway (Newby et al 1998). In addition, this
association may reflect the chronic stimulation and up-regulation of basal
t-PA release secondary to the presence of atheroma (Steins et al 1999) and
arterial denudation. The subsequent depletion of endothelial cell t-PA
stores, the associated increases in PAI-1 concentrations and the overall
reduction of the acute dynamic fibrinolytic response, would potentially be
detrimental. This hypothesis is consistent with the epidemiological
observations of a positive correlation between plasma t-PA and PAI-1
antigen concentrations and future coronary events (Hamsten et al 1985;
Meade et al 1986; Jansson et al 1993; Meade et al 1993; Ridker et al
1993a; Thompson et al 1995; Thogersen et al 1998) as well as our findings
of inverse correlations between the release of active t-PA, and basal
coronary sinus t-PA and PAI-1 antigen concentrations.
Questions of cause and effect cannot be resolved by the present study but
our observations are also consistent with a reduced fibrinolytic activity
causing enhanced atherogenesis. Detailed post-mortem studies have shown
that plaque growth is induced by episodic subclinical plaque disruption
and thrombus formation (Mann & Davies 1999). The prolonged presence
of residual thrombus over a disrupted or eroded plaque will provoke
smooth muscle migration and the production of new connective tissue,
leading to plaque expansion (Galis et al 1997; Nomura et al 1999; Davies
2000). This is consistent with the enhanced macrovascular fibrin
deposition and atherogenesis seen in genetic murine models of t-PA and
plasminogen deficiency (Xiao et al 1997; Christie et al 1999).
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In agreement with our previous work in the peripheral circulation (Newby
et al 1999a), we have also observed an elevated basal plasma t-PA antigen
concentration and an impairment in coronary release of active t-PA in
cigarette smokers. These observations suggest that the increased risk of
coronary thrombosis seen in smokers (Burke et al 1997) relates to impaired
endogenous fibrinolysis and the propagation of thrombus that would
otherwise undergo lysis and remain sub-clinical. Although cigarette
smokers have a higher overall mortality from myocardial infarction than
non-smokers (Haheim et al 1993), the in-hospital mortality is lower
(Mueller et al 1992; Barbash et al 1993; Zahger et al 1995). This so-called
"smokers' paradox" can be explained by the observation that the infarct
related artery is more than twice as likely to become patent in current
smokers compared to non-smokers following thrombolytic therapy for
acute myocardial infarction (Gomez et al 1993; Zahger et al 1995; De
Chillou et al 1996). Indeed, it has been suggested that thrombolytic therapy
should only be given to smokers, and that alternative strategies such as
primary angioplasty used in non-smokers (Bowers et al 1996). Our
findings may account for these observations since it might be anticipated
that patients with impaired endothelial cell t-PA release would benefit
most from thrombolytic therapy whilst those with a normal endogenous
fibrinolytic capacity are more likely to have coronary thrombus resistant to
fibrinolysis.
Previous studies (Zeiher et al 1991; Kuga et al 1995) have suggested that
there is a direct association between coronary atherosclerosis and
endothelium-dependent vasodilatation. These studies have assessed the
vasomotor responses and the extent of atherosclerosis using quantitative
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coronary angiography (QCA). There are several inherent limitations and
inaccuracies of QCA (Newby 2000b) which permits only crude estimates
of plaque load (De Feyter et al 1991; Topol & Nissen 1995) and
underestimates the coronary artery luminal diameter and cross-sectional
area (De Scheerder et al 1994; Escaned et al 1996; Moussa et al 1999).
These inaccuracies occur because QCA can only assess the arterial lumen
and the arterial wall is extrapolated from a reference segment and does not
take account of "Glagovian" remodelling (Glagov et al 1987; Escaned et al
1996). In contrast, IVUS provides a more accurate assessment of
intracoronary plaque volume that has been extensively validated
(Hausmann et al 1994; von Birgelen et al 1997). Using this methodology,
we have failed to detect a direct association between the atherosclerotic
plaque burden and substance P induced vasodilatation. This is, in part,
likely to reflect the independent influence of atherosclerotic risk factors on
endothelium-dependent vasomotion and is bome out by the correlation of
the substance P vasodilatation and the prevalence of these risk factors.
Study Limitations
The proportionate increase in coronary plasma t-PA concentrations appears
to be more modest than that obtained from the forearm circulation in
healthy volunteers (Newby et al 1997b) and is likely to reflect a number of
factors including the direct influence of atherosclerosis. Because the
coronary sinus also drains regions of the heart outwith the left anterior
descending coronary artery territory, the current methodology will also
tend to underestimate the net coronary release of t-PA. Moreover, regional
and visceral differences in t-PA release do exist such that the upper limbs
release four times the amount of the lower limbs (Keber 1988), and unlike
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the systemic circulation, the liver and kidney do not acutely release t-PA
when challenged with desmopressin (Brommer et al 1988).
Since the estimated net t-PA release was defined as a product of the
arteriovenous difference and plasma flow, impaired endothelial
vasodilatation may contribute to the observed reduction in net release of
active t-PA. However, this is unlikely for two reasons. First, there was an
independent correlation between the arteriovenous difference and the
atheromatous plaque burden. Theoretically, smaller increases in blood flow
would be associated with greater increases in the arteriovenous
concentration differences and obscure this latter association. Second, we
failed to detect a significant correlation between the atheromatous plaque
burden and substance P induced vasodilatation.
A clear incremental dose response to substance P infusion was not
observed. The doses of substance P were chosen on the basis of the
effective end-organ concentrations associated with t-PA release in the
forearm (Newby et al 1999a). Given that the left anterior descending
coronary artery blood flow is approximately 4-5-fold forearm blood flow,
we utilised substance P at doses of 10-40 pmol/min (c.f. 2-8 pmol/min in
the forearm) which are at the limit of breakthrough systemic effects
(Crossman et al 1989). These intracoronary doses have previously been
shown to have a similar plateau of vasodilatation responses (Crossman et
al 1989) and are consistent with our own findings.
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In conclusion, we have demonstrated, for the first time, a direct association
between both the coronary atheromatous plaque burden and smoking habit
with the acute local fibrinolytic capacity of the coronary circulation. These
important findings may provide a direct link between endothelial
dysfunction and atherothrombosis. Interventions targeted at the
enhancement of the local fibrinolytic capacity will potentially be of major
importance.
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Table 5.1 Patient Characteristics.
Number 25
Age 56 ± 2 years
Sex 17 male
Body Mass Index 28 ± 1 kg/m2





Serum Lipid Profile Total Cholesterol 5.8 ±0.3 (mmol/L)
LDL Cholesterol 3.2 ± 0.2 (mmol/L)
HDL Cholesterol 1.3 ±0.1 (mmol/L)
Total/HDL Cholesterol Ratio 4.9 ± 0.5
Triglycerides 2.3 ±0.1 (mmol/L)




Lipid Lowering Therapy 16
ACE Inhibition 3
Diuretics 3
Previous Myocardial Infarction 6
Non-Invasive Testing Low Risk 9
High Risk 12
Not Performed 4
Angiographic Data Good Left Ventricular Function 24
Normal/Mild Disease 8
Single Vessel Disease 9
Two Vessel Disease 6
Three Vessel Disease 2
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Table 5.3 Influence
plasminogen activator


















*Area under the curve
tp<0.02; Jp=0.07 (current/ex-smokers versus non-smokers, unpaired t-
test)
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of smoking status on the tissue
(t-PA) release, plasminogen activator
and endothelium-dependent increases in
Plaque Burden 5.8 ±0.8 4.5 ±1.6
Coronary Blood Flow
Basal Blood Flow 104 ±16 93 ±15
Percentage Increase* 129 ± 28 125 ± 42
Plasma t-PA Antigen
Basal Coronary Sinus Concentration 8.7 ± 0.6 6.3 ± 0.7f
Basal Arterial Concentration 8.3 ± 0.6 6.3 ± 0.8J
Arteriovenous Concentration Difference* 2.8 ±1.0 2.6 ±1.2
Estimated Net Release* 98 ± 108 190 ± 85
Plasma t-PA Activity
Basal Coronary Sinus Concentration 0.5 ±0.1 0.6 ± 0.2
Basal Arterial Concentration 0.4 ± 0.1 0.5 ± 0.2
Arteriovenous Concentration Difference* 0.6 ± 0.3 2.8 ± 1.1 f
Estimated Net Release* 42 ±21 202±73f
Plasma PAI-1 Antigen
Basal Coronary Sinus Concentration 73 ± 9 59 ± 14
Basal Arterial Concentration 73 ± 9 60 ±15
Plasma PAI-1 Activity
Basal Coronary Sinus Concentration 17 ± 5 24 ± 8
Basal Arterial Concentration 17 ± 4 23 ± 8
Figure 5.1 Prevalence of risk factors and influences on coronary
blood flow responses to substance P infusion.
Endothelium-Dependent Increases
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Figure 5.2 Correlation of the plaque burden of the left anterior
descending coronary artery with the AUC for the arteriovenous
concentration differences (upper panel) and the estimated net
release (lower panel) of tissue plasminogen activator (t-PA).
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Chapter 6
Influence of Differential Vascular Remodelling on the
Coronary Vasomotor Response
McLeod AL, Newby DE, Northridge DB, Fox KAA, Uren NG.
Influence ofDifferential Vascular Remodelling
on the Coronary Vasomotor Response.
Cardiovasc Res. 2003 Aug l;59:520-6.
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6.1 Abstract
Arterial remodelling may increase or decrease the luminal encroachment of
atherosclerotic plaques in the coronary circulation. However, the factors
determining the nature and consequences of the remodelling process
remain poorly characterized. The study aims were to assess whether the
pattern of vascular remodelling influences the physical and vasomotor
responses of the coronary arteries in vivo in man. Coronary vessel area,
distensibility and stiffness were determined in positively, negatively and
non-remodelled arterial segments using intravascular ultrasound and
Doppler flow measurement. Epicardial vasomotor responses were
determined following intracoronary boluses of acetylcholine (10"6M and
10"4M), adenosine (24-30pg) and nitroglycerin (200pg). Fifty-six coronary
arterial segments were studied in 25 patients. In comparison to non- and
positively remodelled segments, negatively remodelled segments had a
higher stiffness index (67±16 vs. 33±5 and 38±8 respectively; p<0.02) and
appeared to have lower compliance and distensibility (0.66±0.17 vs.
1.65±0.54 and 0.94±0.18 /mmHg; p=NS). Non-remodelled segments had a
greater change in vessel area with 10"6 M acetylcholine (4.9±0.8%),
compared to positively and negatively remodelled segments (0.6±1.8%
and -4.9±1.8% respectively, p<0.05). A significant degree of preservation
of vasodilatation to 10"6 M acetylcholine was evident in positively
remodelled compared with negatively remodelled segments (p<0.05).
Nitroglycerin caused greater vasodilatation in non-remodelled segments
(7.2±3.8%) than either positively or negatively remodelled segments
(4.7±0.9% and 3.7±0.6% respectively, p<0.05). Vascular remodelling is an
important and major determinant of local epicardial vasomotor responses.
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Both structural and functional abnormalities are associated with negative
remodelling that may contribute to the adverse effects of such lesions.
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6.2 Introduction
Coronary arterial remodelling is described by the response of the arterial
wall to the presence of an atherosclerotic plaque. In many cases, the artery
expands to accommodate the developing plaque burden such that there
may be little or no luminal encroachment: so-called positive remodelling
(Glagov et al 1987). However, this vascular expansion may be absent
(non-remodelled) or reversed (negatively remodelled) leading to more
rapid luminal encroachment and the development of significant flow-
limiting stenoses. The remodelling process can consequently have a
profound influence on the outcome of atheroma deposition with the same
plaque burden leading to either an absent (positive remodelling) or
significant (negative remodelling) luminal stenosis and myocardial
ischemia. To date, the factors determining the nature and consequences of
the remodelling process remain poorly characterized.
Since the seminal work of Furchgott and Zawadski, it has been widely
recognized that the endothelium can influence vascular tone through an
array ofmediators (Furchgott and Zawadski 1980). Endothelial stimulation
results in the rapid release of vasodilator mediators, including prostacyclin,
nitric oxide and endothelium-derived hyperpolarising factor, as well as
vasoconstrictor mediators, such as angiotensin II and endothelin-1. Indeed,
both nitric oxide and endothelin-1 are released continuously by the
endothelium to regulate basal vascular tone and blood pressure (Vallance
et al 1989; Haynes et al 1993; Haynes et al 1996). Thus, there is an
inextricable interplay between these endothelium-derived vasodilator and
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vasoconstrictor mediators that have a local counter-regulatory paracrine
action on the adjacent vascular smooth muscle (Verharr et al 1998).
The endothelium responds to physical changes within the vascular lumen,
such as leucocyte adhesion and alterations in shear stress, and the vessel
wall, such as barotrauma and lipid deposition. Given these interactions, the
integrity of endothelial function may profoundly influence the local vessel
wall response to lipid deposition and atheroma formation (Newby et al
2001), and thereby determine the resultant pattern of vascular remodelling
(Lerman et al 1998; Sudhir et al 1995). However, the exact relationship
between endothelial function and the direction of vascular remodelling in
atherosclerotic coronary arteries is unclear.
The purpose of the present study was to assess whether the pattern of
vascular remodelling influenced the physical and vasomotor responses of
the coronary arteries in vivo in man. Using intravascular ultrasound
(IVUS) and Doppler flow velocity measurement, the resting physical
characteristics of vascular remodelling were determined, and the
endothelium-dependent and -independent vasomotor function was




Twenty-five patients (20 male, mean age 59±2 years) with angiographic
evidence of mild to moderate coronary artery disease were recruited at the
time of coronary angiography in two centres (Royal Infirmary and Western
General Hospital, Edinburgh, UK). Patients were excluded if they had
severe left main stem disease, left ventricular hypertrophy or significant
concurrent illness. All patients had their coronary risk factors determined
by standard clinical criteria. Hypercholesterolemia was defined as a fasting
total cholesterol >200 mg/dL prior to initiation of lipid lowering therapy.
The study was undertaken with the approval of the local research ethics
committee, in accordance with the principles outlined in the Declaration of
Helsinki, and the written informed consent of each subject.
6.3.2 Study Protocol
All patients discontinued their medication on the study day, attended fasted
and underwent diagnostic coronary angiography. Standard diagnostic
images were taken using the Judkin's technique with a non-ionic contrast
agent (Niopam™ 340, MERCK Pharmaceuticals, Middlesex, UK). A non-
tortuous, non-branching segment of artery with a reference luminal
diameter of >3.0 mm and luminal irregularity (diameter stenosis of 20-
70%) was then identified for IVUS assessment. Where percutaneous
coronary intervention was planned, the study was performed in an adjacent
artery prior to the interventional procedure.
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A 7 French guiding catheter was used to cannulate the left or right
coronary artery and, following a 5,000 IU intravenous bolus of heparin
(Leo Laboratories Ltd., Princes Risborough, UK), a 0.014 inch 12.5 MHz
Doppler wire (Flowire™, Endosonics, Rancho Cordova, CA) was passed
across the arterial segment under study. A 3.2 F Ultracross™ 30 MHz
IVUS imaging catheter (Atlantis SCIMED®, Boston Scientific
Corporation, Maple Grove, MN) was advanced over the Doppler wire
(Nitrocine™, SCWARZ Pharma Ltd, Chesham, UK).
The IVUS examination of the proximal artery was performed at 0.5 mm/s
using a motorized pullback device (Boston Scientific Corporation). All
IVUS images were recorded on high fidelity s-VHS videotape for later off¬
line quantitative analysis. Subsequent three-dimensional computerized
reconstruction of the two-dimensional IVUS images was performed using
the TomTec™ system (TomTec GmbH, Munich, Germany).
6.3.3 Assessment of Remodelled Segments
During the automated pullback, potential regions of interest (remodelled
segments) were identified. Segments were selected for inclusion in the
study if there was optimal image quality without rotational, angular or
image artifacts; clear demarcation of the endoluminal and the external
elastic laminal borders; and less than 180 degrees of calcification.
Segment remodelling was defined according to existing criteria based on
the vessel area at the index site relative to normal or near-normal proximal
and distal reference segments. IVUS pullbacks were acquired to define
these regions. This enabled classification of the remodelled segment by
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calculating the relative vessel area as the ratio of the vessel area at the
index segment to the mean of the vessel area at proximal and distal
reference segments. Categorization of segments was defined as follows:
non-remodelled segments = vessel area ratio of >0.95 and <1.05;
positively remodelled segments = ratio of >1.05; and negatively
remodelled segments = ratio of <0.95.
6.3.4 Drug Administration
Following the pullback examination, the IVUS imaging catheter was
repositioned at the index segment. The Doppler guide wire was retracted
to the tip of the imaging catheter and maintained in a stable position by the
short monorail segment of the IVUS catheter (Schwarzacher et al 2000;
-6 -4
Newby et al 2000). Acetylcholine at a dose of 10 M and 10 M
(Miochol™, OMJ Pharmaceuticals Inc.), adenosine at a dose of 24-30 pg
(Sanofi Winthrop Ltd, Guildford, UK) and nitroglycerin at a dose of 200
pg (Schwarz Pharma Ltd) were given as 2 mL boluses, followed by 2 mL
0.9% saline flush via the guide catheter (Newby et al 2000). The IVUS
images and Doppler ultrasound were recorded simultaneously to allow the
measurement of luminal area and blood flow velocity for two minutes
following each drug bolus.
6.3.5 Ultrasound Measurements
Coronary artery cross-sectional area (vessel and luminal area) was
measured using computerized planimetry (Clearview™, Boston Scientific
Corporation.) of the vessel lumen at the onset of the QRS complex
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(diastole) and the offset of the T wave (systole) (Jeremias et al 2000).
Blood flow velocity was determined using average peak velocity of the
Doppler wire signal. Coronary artery blood flow was previously defined
as half the product of the average peak velocity and the diastolic luminal
cross-sectional area (Newby et al 2000; Doucette et al 1992). The
atheromatous plaque volume was calculated using a well-validated edge
detection algorithm as previously described and was expressed as mm3 per
mm of vessel (Newby et al 2000; von Birgelen et al 1996; von Birgelen et
al 1997). The distensibility index of the coronary artery was defined as
[(aA/A)/ aP] x 103/mm Hg; where aA represents the luminal area change
between systole and diastole, A the smallest luminal area in diastole, and
aP the difference in systolic and diastolic blood pressure (Jeremias et al
2000; Nakatani et al 1995; Yamagishi et al 1997). The stiffness index, (3,
was calculated using the following equation: (3 = [ln(Psys/Pdias)]/(ad/D),
where Psys represents the systolic pressure, Pdias the diastolic pressure, aD
the difference between systolic and diastolic mean lumen diameters, and D
the diastolic mean luminal diameter (Jeremias et al 2000; Hirai et al 1989).
6.3.6 Data Analysis and Statistics
Data were examined by analysis of variance (ANOVA) with repeated
measures and Student's t-test using StatView v5.0.1 (SAS Institute Inc.,
Cary, NC). Where ANOVA demonstrated significant differences in
responses, post-hoc comparisons were made using the Fisher protected
least significant difference test (StatView v5.0.1). All results are expressed




Baseline patient characteristics are shown in Table 6.1. The majority of
patients had at least one risk factor for coronary artery disease; in
particular, a history of hypercholesterolemia (19/25). A maximum of three
segments were selected in each artery to give a total of 56 segments: 28
non-remodelled, 15 positively remodelled and 13 negatively remodelled.
The left anterior descending artery was studied in 12 patients, right
coronary artery in 6 patients, and left circumflex coronary artery in 7
patients. Heart rate and mean arterial pressure were stable throughout the
study in all subjects. There were no procedural or post-procedural in-
hospital complications.
6.4.1 Characteristics of Vessel Segments
Non-remodelled segments (4.4 ±0.8 mm2) had significantly less plaque
cross-sectional area than either positively remodelled (8.0 ± 1.1 mm2,
p<0.05)or negatively remodelled (7.1 ± 0.6 mm2, p<0.01) segments. Total
vessel cross-sectional area was similar for the three types of vessel
remodelling (Figure 6.1). Negatively remodelled segments had a higher
stiffness index in comparison to non- and positively remodelled segments
(67±16 vs. 33±5 and 38±8 respectively; p<0.02) and with a trend towards a





Acetylcholine, adenosine and nitroglycerin all caused coronary resistance
vessel vasodilatation and an increase in coronary artery blood flow
(pD 0.002; Figure 6.2) with adenosine causing the largest increase
(p<0.004 vs. other agents). There were no differences in the resistance
vessel responses between the three remodelling groups.
Conduit Vessels
All vessel segments vasodilated to adenosine and nitroglycerin, and
vasoconstricted to 10"4 M acetylcholine (p<0.05 for all; Figure 6.3). The
vasomotor response to acetylcholine 10"6 M varied according to the
category of vascular remodelling (p<0.001; Figure 6.3). Non-remodelled
segments had a greater change in vessel cross-sectional area with 10"6 M
acetylcholine (4.9±0.8%), compared to positively and negatively
remodelled segments (0.6±1.8% and -4.9±1.8% respectively, p<0.05). A
significant degree of preservation of vasodilatation to 10"6M acetylcholine
was evident in positively remodelled compared with negatively remodelled
segments (p<0.05). There was a trend towards greater adenosine-induced
vasodilatation in non-remodelled segments (increase in vessel cross-
sectional area of 6.2 ±1.0 %) compared with positively (3.7 ± 0.8 %) and
negatively (3.9 ± 0.9%) remodelled segments (p=0.14, Figure 6.3).
Similarly, nitroglycerin caused greater vasodilatation in non-remodelled
segments (increase in vessel cross-sectional area of 7.2 ± 3.8 %) than
either positively (4.7 ± 0.9 %) or negatively (3.7 ± 0.6%) remodelled
segments (p<0.01, Figure 6.3).
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6.5 Discussion
We have demonstrated that, in keeping with a more fibrotic and
vasospastic response to atheroma deposition, negatively remodelled
coronary arterial segments are stiffer and less distensible. Moreover, we
have shown that the type of vascular remodelling determines the local
epicardial vasomotor response to both endothelium-dependent and -
independent vasodilators. In particular, negatively remodelled segments
have an exaggerated vasoconstrictor response to acetylcholine and
impaired endothelium-independent vasodilatation. We conclude that
negative remodelling is associated with more pronounced local vascular
and endothelial dysfunction.
Endothelial Function
At the lowest concentration of acetylcholine, there was preservation of
endothelium-dependent vasodilatation in non-remodelled segments and, to
a lesser extent, positively remodelled segments. However, in negatively
remodelled segments, low dose acetylcholine caused vasoconstriction that
was equivalent to that observed with high dose acetylcholine in all
segments. The phenomenon of paradoxical epicardial vasoconstriction
during acetylcholine administration in atherosclerotic coronary arteries
was first described 15 years ago (Ludmer et al 1986). It has been attributed
to the direct muscarinic vasoconstrictor action of acetylcholine on the
vascular smooth muscle cells in the absence of functional endothelium-
dependent vasodilatation. Consistent with previous work (Nishimura et al
1995), our observation of low dose acetylcholine-induced vasoconstriction
cannot be directly attributed to the atherosclerotic plaque burden since both
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positively and negatively remodelled segments had a similar plaque load
but distinct vasomotor responses. It may, in part, be explained by the
reduced vasodilatation response to the endothelium-independent
vasodilator, nitroglycerin, suggesting impaired vascular smooth muscle
sensitivity to nitric oxide in remodelled segments. However, this cannot be
the only explanation since the reduced response to nitroglycerin was
observed in both positively and negatively remodelled segments but only
negatively remodelled segments demonstrated vasoconstriction to low
dose acetylcholine. This suggests that negative remodelling is associated
with endothelial dysfunction or alterations in muscarinic receptor
responsiveness.
Vascular Remodelling
The current finding of an association between negative remodelling and
vascular dysfunction does not address the question of cause and effect. It is
tempting to speculate that localized vascular and endothelial dysfunction
may lead to a more vasospastic artery that would cause increased vessel
stiffness and negative remodelling. Alternatively, these features may have
a common etiology with the potentially more fibrotic and inflammatory
reaction to atheroma formation not only leading to negative remodelling
but also vascular and endothelial dysfunction. In this regard, longitudinal
studies would be of value to monitor the changes in vascular function and
vessel remodelling over time in order to determine which is the dominant
factor in determining these vascular effects. This would also determine if
vessels negatively remodel from the beginning or go through an initial
phase of positive remodelling which becomes exhausted through
progressive endothelial dysfunction and fibrosis (Ward et al 2000). In a
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hypercholesterolemic rabbit model, endothelial dysfunction was associated
with negative remodelling and restenosis after balloon injury implicating
endothelial dysfunction in the causation of negative remodelling (Lafont et
al 1999).
Irrespective of the causative relationship, the present study suggests that
there are functional abnormalities associated with coronary artery
remodelling in addition to anatomical and structural changes. There has
been only one previous study to address this issue. Lerman and colleagues
used quantitative coronary angiography to determine epicardial responses
to 10"4 M acetylcholine and nitroglycerin in the left anterior descending
coronary artery (Lerman et al 1998). This study used a single dose of
acetylcholine and employed a different classification of vascular
remodelling. However, consistent with our current findings, Lerman and
co-workers suggested that positive remodelling is associated with
endothelial dysfunction. We have now extended these observations by
providing more detailed assessments of remodelled segments, and
demonstrating that negative remodelling is associated with more
pronounced endothelium-dependent and -independent vasomotor
abnormalities.
Study Limitations
This study was conducted in the necessary clinical setting of patients with
a combination of risk factors and concomitant therapies undergoing
diagnostic coronary angiography. The modest sample size means that this
study lacks sufficient power to address the influence of all the individual
variables associated with coronary artery disease. The study was also
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performed at a single time point and temporal changes in the remodelling
process are unknown.
We defined the remodelling segment with reference to proximal and distal
segments. Because of the clinical setting of this study, some of these
segments will have incorporated some mild degree of atherosclerotic
plaque: the so-called 'near-normal' segments. Because this could
theoretically affect the classification of the remodelling segments, we
avoided arterial segments where the remodelling classification was
unclear. It should also be recognised that our findings may not be
representative of all coronary artery atherosclerotic plaques. Heavily
calcified lesions were excluded because the resultant acoustic shadow
makes it very difficult to measure vessel areas. In addition, whilst we
excluded segments with rotational, angular or image artifacts, we cannot
completely eliminate these effects and recognise this as a potential
limitation.
Conclusions
Vascular remodelling is an important and major determinant of epicardial
vasomotor responses. Both structural and functional abnormalities are
associated with negative remodelling that may contribute to the adverse
effects of such lesions.
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Table 6.1 Patient characteristics (n=25).
N %









Current smoker 9 36
Hypertension 12 48
Family history of premature vascular disease 10 40
Type 2 diabetes mellitus 3 12




Calcium antagonist 13 52
Long-acting nitrate 13 52
Lipid lowering agent 15 60
ACE Inhibitor 1 4
Coronary Angiography
Normal/ mild disease 5 20
Single vessel disease 6 24
Two vessel disease 7 28
Three vessel disease 8 32
ACE - angiotensin-converting enzyme; LDL - low density lipoprotein;
HDL - high density lipoprotein.
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Figure 6.1 Baseline physical characteristics of non- (white bars),
positively (gray bars) and negatively (black bars) remodelled













Figure 6.2 Baseline (white bars) and peak (black bars)
coronary blood flow (percentage change, gray bars) to















Acetylcholine Acetylcholine Adenosine Nitroglycerin
(106 M) (104 M) (24-30 pg) (200 pg)
ANOVA for comparison of percentage increase in blood flow for the 4
drug boluses.
Paired r-test for comparison of baseline and peak blood flow for each drug
bolus.
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Figure 6.3 Changes in vessel area following intracoronary
acetylcholine, adenosine and nitroglycerin in non- (white bars),






















ANOVA for comparison of remodelled segment types.
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7.1 Conclusions
7.1.1 CoronaryArtery Remodelling and Spectral Analysis ofPlaque.
With negative remodelling predisposing to increasing luminal stenosis and
myocardial ischaemia, positively remodelled segments have been
associated with unstable lesions (Schwarzacher et al 1998; Jeremias et al
2000, Shoenhagen et al 2000). Using spectral analysis of in vivo
radiofrequency intravascular ultrasound backscatter, plaque composition
was similar with fibrous plaque predominant in both remodelled types,
suggesting this is not an integral determinant of unstable lesions.
Positively remodelled segments were found, however, to have a larger
plaque burden and that may be a factor in unstable lesions in addition to
other pathophysiological mechanisms such as shear stress, vascular
compliance, matrix metalloproteinase activity and inflammation. We have
however only studied patients with stable coronary artery disease and our
findings may not be applicable in patients with acute coronary syndromes.
The ability to characterise plaque composition, using spectral analysis of
radiofrequency intravascular ultrasound backscatter may have important
implications in both the identification and in monitoring the response of
plaque to therapy such as lipid-lowering medication.
7.1.2 Coronary Plaque Load and Non-Invasive Assessment of Aortic
Stiffness.
We have demonstrated using intravascular ultrasound and applanation
tonometry that coronary artery plaque load correlates with carotid-radial
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pulse wave velocity and appears to correlate with carotid-femoral pulse
wave velocity. Other measures reflecting aortic stiffness (aortic
augmentation and augmentation index) did not reveal positive associations
with plaque load.
Our study population had a combination of risk factors for coronary artery
disease that contributes to arterial stiffness (Cockcroft et al 1991).
Hypercholesterolaemia is associated with endothelial dysfunction and
impaired endogenous nitric oxide release (Chowienczyk et al 1992; Stoes
et al 1995). Arterial stiffness is increased by both nitric oxide synthase
inhibition and hypercholesterolaemia (Iannuzzi et al 1999; Wilkinson et al
2002). Furthermore treatment with lipid lowering therapy improves
endothelial function and increases the bioavailability of nitric oxide (Stroes
et al 1995; Leung et al 1993).
There was no positive association demonstrated with both aortic
augmentation and augmentation index with plaque load. With the modest
sample size, the study lacked sufficient power to address the influence of
all the individual variables associated with coronary artery disease which
potentially could create a type II error. By necessity, many of the study
patients were established on concomitant medical therapy. Treatments
such as P-adrenergic receptor blockade and angiotensin-converting enzyme
inhibition have been shown to influence aortic stiffness (Ting et al 1991;
Breithaupt-Grogler et al 1996). However, whilst such treatments may
affect the functional aspects of arterial stiffness, the structural component
of arterial stiffness will be unaffected. Furthermore because of ethical and
technical considerations IVUS was not performed in vessels with a severe
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luminal stenosis nor was it performed on all three epicardial vessels which
may have underestimated the overall plaque burden.
The association between coronary artery plaque volume and aortic
stiffness may, in part, reflect the common aetiological for atherosclerosis
that will inevitably exist in the clinical population. However, the results
suggest that pulse wave velocity may be a useful non-invasive surrogate
marker for the extent of coronary atherosclerosis.
7.1.3 Coronary Plaque Load and Endothelial Function
Previous studies (Zeiher et al 1991; Kuga et al 1995) have suggested that
there is a direct association between coronary atherosclerosis and
endothelium-dependent vasodilatation. These studies have assessed the
vasomotor responses and the extent of atherosclerosis using quantitative
coronary angiography (QCA). There are several inherent limitations and
inaccuracies of QCA (Newby 2000b) which permits only crude estimates
of plaque load (De Feyter et al 1991; Topol & Nissen 1995) and
underestimates the coronary artery luminal diameter and cross-sectional
area (De Scheerder et al 1994; Escaned et al 1996; Moussa et al 1999).
These inaccuracies occur because QCA can only assess the arterial lumen
and the arterial wall is extrapolated from a reference segment and does not
take account of coronary artery remodelling (Glagov et al 1987; Escaned et
al 1996). In contrast, IVUS provides a more accurate assessment of
intracoronary plaque volume that has been extensively validated
(Hausmann et al 1994; von Birgelen et al 1997). Using this methodology,
we have failed to detect a direct association between the atherosclerotic
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plaque burden and substance P induced vasodilatation. In contrast, there
was an association between the number of risk factors for atherosclerosis
and the coronary blood flow responses to substance P, suggesting an
independent influence of atherosclerotic risk factors on endothelium-
dependent vasomotion.
Endothelial function as assessed by endothelial derived t-PA release, in the
coronary circulation, correlated inversely with plaque load. The impaired
coronary release of active t-PA in cigarette smokers suggests that in the
presence of atheroma, this adversely influences the local fibrinolytic
balance in the coronary circulation and may provide a link between
endogenous fibrinolysis, endothelial dysfunction and athero-thrombosis.
With endothelial fibrinolytic dysfunction appearing to relate to cigarette
smoking and plaque load and not to hypercholesterolaemia (Newby et al
2002), this would indicate that endothelial dysfunction can be manifest in
separate distinct pathways depending upon the nature of the insult.
7.1.4 Coronary Artery Remodelling and Vascular/Endothelial
Function.
Coronary artery remodelled segments were defined using IVUS and
combined with an assessment of the epicardial response to vasoactive
agents this provided functional information in terms of local vascular and
endothelial dysfunction.
Negatively remodelled segments were found to be stiffer and less
distensible, suggesting a less dynamic segment in vasoactive terms. In
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contrast the greater distensibility in positively remodelled segments was in
keeping work by Jeremias et al who postulated that this was reflective of
increased pulsatile stretch and preserved endothelial function with nitric
oxide release (Jeremias et al 2000).
We have shown that the type of vascular remodelling determines the local
epicardial vasomotor response to both endothelium-dependent and -
independent vasodilators. In particular, negatively remodelled segments
have an exaggerated vasoconstrictor response to acetylcholine and
impaired endothelium-independent vasodilatation. With similar plaque
loads between positively and negatively remodelled types and similar
changes in vessel area to nitrogylcerine, this suggests that negative
remodelling is associated with a greater degree of endothelial dysfunction
or alterations in muscarinic receptor responsiveness (to acetylcholine).
With the absence of longitudinal studies it is unclear as to whether positive
and negative remodelling are parts of the same pathological process, but at
different time points of development. Different types of remodelling were
present in the same vessel suggesting that lesion specific factors for
example plaque type, degree of inflammation and shear stress were more
important than patient-specific factors. Ideally, longitudinal studies would
be of value in determining which factors are dominant in determining the
remodelling type, though the use of reference segments to define the extent
of remodeling assumes that the reference site reflects the lesion site at an
earlier time and also it becomes less accurate with diffuse disease.
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We have shown that negatively remodelled segments are more
vasoconstricted segments and are associated with endothelial dysfunction
in the presence of similar plaque loads, compared with positively
remodelled segments. This would suggest that in negatively remodelled
segments there is impairment of smooth muscle relaxation and release of
nitric oxide compared to positively remodelled segments. The increased
resistance to pulsatile stretch and nitric oxide release would imply less
fluidity in the matrix skeleton of the vessel wall.
As a consequence, the remodelling process can consequently have a
profound influence on the outcome of atheroma deposition with a plaque
burden leading to either positive remodelling with potential for unstable
lesions, or negative remodelling with luminal stenosis and resultant
myocardial ischaemia. Lipid lowering therapy and ACE inhibition have
been associated with improvement in endothelial function (Treasure et al
1995; Anderson et al 1995; Lippy et al 2003) and plaque stabilisation
(Hornig et al 1997, Dzau et al 2002; Lippy et al 2003). Although
speculative, with preservation or enhancement of endothelial dysfunction
this may protect against negative remodelling and resultant luminal
encroachment in the presence ofplaque load.
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7.2 Future Directions
Intravascular ultrasound offers a unique opportunity to assess the coronary
atherosclerotic burden by providing information regarding the severity,
composition, and distribution of atheroma. With IVUS, positive
remodelling and larger plaque areas have been shown to be more prevalent
in unstable lesions (Pasterkamp et al 1998; Schwarzacher et al 2000;
Shoenhagen et al 2000), whereas patients who presented with stable angina
were more likely to present with negative remodelling (Shoenhagen et al
2000)
The disparity between angiographic dimensions and clinical outcome seen
in the multicentre lipid-lowering trials (Brown et al 1993)) suggests that
the ability to study relatively mild (<50% diameter stenosis by
angiography) but potentially unstable stenoses by intravascular ultrasound
may give additional information regarding clinical outcome. With
longitudinal studies, the interaction between the atheroma load and the
change in vessel and lumen dimensions can be accurately assessed in vivo.
Schartl and colleagues compared the effects of 12 months aggressive lipid
lowering therapy with standard lipid lowering therapy in 131 patients
using serial 3D intracoronary ultrasound (Schartl et al 2001). Whilst no
effect was seen on plaque volume, there was a significant change in the
apparent composition of the atherosclerotic plaque. Aggressive LDL
cholesterol reduction was associated with an increase echogenicity of the
atherosclerotic plaque indicating a reduction in lipid content and greater
plaque stability.
144
The recently reported REVERSAL study compared the effects of intensive
versus moderate lipid lowering on changes in atheroma burden measured
by intravascular ultrasound. The primary efficacy parameter was the
percentage change in atheroma volume over 18 months. Whilst there was a
significant 2.7% increase in plaque volume in the moderate lipid lowering
arm there was no change in the intensive arm, suggesting a greater
reduction in atherogenic lipoproteins (Nissen et al 2003).
With on-going development of non-invasive imaging of coronary arteries
with MRI and ultrafast CT, it is possible that that serial studies in humans
may become more feasible. Furthermore, further anticipated reductions in
the size of IVUS catheters and higher frequency catheters as well as the
high resolution (20 pm) offered by optical computed tomography (see
below) which is also catheter-based, may allow the accurate and
reproducible plaque characterisation and an endpoint of plaque
vulnerability assessment. Recent advances in intravascular imaging have
provided several additional modalities to characterise atheroma with the
ability to identify vulnerable plaque in vivo by using various features of
plaque vulnerability asmethods of identification.
IVUS Elastography.
IVUS permits real-time visualisation of coronary arteries and resultant
changes in systole and diastole. IVUS elastography combines ultrasound
radiofrequency data with images of local strain. In-vitro work using
intravascular elastography to characterise fibrous, fibro-lipid and lipid
plaque types revealed higher strains in the lipid plaque types indicating its
potential for determining plaque type (de Korte et al 2000). A positive
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correlation was demonstrated, ex vivo, with strain measurements and
macrophage presence, with an inverse relation to the amount of smooth
muscle cells, demonstrating potential to identify vulnerable plaque (Schaar
et al 2002). De Korte et al recently described an in vivo animal study
validating IVUS elastographic criteria for identifying lipid-rich plaque,
demonstrating a sensitivity and specificity of 92% in identifying the
presence of macrophages at foci of increased strain within the plaque (de
Korte 2002).
Optical Coherence Tomography (OCT).
Optical Coherence Tomography (OCT) is a catheter-based imaging
modality which measures backscattered infrared light directed at the
arterial wall. With ex-vivo histological correlation, plaque morphology
was identified with sensitivity and specificity of 92% and 94%,
respectively for lipid rich plaque; 95% and 100% for fibrocalcific plaque;
and 87% and 97% for fibrous plaque (Yabushita et al 2002). A small in-
vivo study, demonstrated that OCT was equivalent to IVUS in detecting
plaque and differentiating between echolucent regions, fibrous plaques and
macrocalcifications in coronary atheroma (Jang et al 2002). OCT has also
been recently shown to be able to detect and quantify macrophage
infiltration within the fibrous cap (Tearney et al 2003). Combining other
modalities with OCT includes light polarisation imaging, elastography and
spectroscopy with biochemical analysis of plaque types.
Further Areas.
Other developing invasive imaging modalities include intravascular
magnetic resonance imaging, direct visualisation of the arterial wall with
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angioscopy, intracoronary thermography, where micro-elevations in
temperature reflecting inflammatory activity and potential vulnerability
can be detected.
Developing pharmacological interventions include targeting specific
receptor activation and cell metabolism. Magnetic nanoparticle based
contrast agents have been developed that display enzyme specific
fluorescence detectable by optical or fluorescence-mediated tomography
(Josephson et al 2002). Alternatively, using intravascular ultrasound,
antibody labeled and contrast loaded microspheres have been developed
that bind directly to selected antigens on cell surfaces (BHF RG/2000014).
These techniques have the potential to target specific components of the
atherosclerotic plaque in vivo, for example, specific vascular cell proteins,
receptors or inflammatory cells and to locally deliver drug therapies. This
would provide the prospect of relating the structural characteristics of the
endothelium and vascular wall to its in vivo function
With characterisation of coronary plaques and identification of
vulnerability, this would be an important diagnostic contribution to the
clinician in both risk assessment, targeting therapies and in monitoring the
response of plaque to current pharmacological therapies such as statin,
ACE inhibitors, angiotensin receptor blockers and newer therapies such as
peroxisomal proliferator activator receptor agonists.
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